• Abad S, Seve P, Dhote R, Brezin AP. Guidelines for the management of uveitis in internal medicine. Rev. Med. Interne. 30: 492-500 (2009).

• Abdallah A, Sato H, Grutters JC, Veeraraghavan S, Lympany PA, Ruven HJ, van den Bosch JM, Wells AU, du Bois RM, Welsh KI. Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun. 4: 450-454 (2003). *

• Abdelghani A, Khalifa M, Mezghani S, Hayouni A, Bahri F, Garrouche A, Klabi N, Benzarti M, Jerray M. Common variable immunodeficiency: a 7 cases reported. Tunis. Med. 85: 734-737 (2007).

• Abdullgaffar B. Review article: granulomatous diseases and granulomas of the appendix. Int. J. Surg. Pathol. 18: 14-20 (2010).

• Abe C, Iwai K, Mikami R, Hosoda Y. Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralbl. Bakteriol. Mikrobiol. Hyg. [A] 256: 541-547 (1984).

• Abebe F, Mustafa T, Nerland AH, Bjune GA. Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease. Clin. Exp. Immunol. 143: 180-192 (2006). *

• Abraham SC, Poterucha JJ, Rosen CB, Demetris AJ, Krasinskas AM. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests. Am. J. Surg. Pathol. 32: 965-973 (2008).

• ACCESS Research Group. Design of a case control etiologic study of sarcoidosis (ACCESS). J. Clin. Epidemiol. 52: 1173-1186 (1999).

• Ackermann D. Hypercalcemia in sarcoidosis - case report, prevalence, pathophysiology and therapeutic options. Ther. Umsch. 64: 281-286 (2007).

• Agostini C, Cabrelle A, Calabrese F, Bortoli M, Scquizzato E, Carraro S, Miorin M, Beghe B, Trentin L, Zambello R, Facco M, Semenzato G. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. Am. J. Respir. Crit. Care Med. 172: 1290-1298 (2005). *

• Agostini C, Costabel U, Semenzato G. Sarcoidosis news: immunologic frontiers for new immunosuppressive strategies. Clin. Immunol. Immunopathol. 88: 199-204 (1998). *

• Ahmed I, Harshad SR. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease? J. Am. Acad. Dermatol. 54: 55-60 (2006).

• Aiello M, Chetta A, Marangio E, Zompatori M, Olivieri D. Pleural involvement in systemic disorders. Curr. Drug Targets Inflamm. Allergy 3: 441-447 (2004).

• Akahoshi M, Ishihara M, Namba K, Kitaichi N, Ando Y, Takenaka S, Ishida T, Ohno S, Mizuki N, Nakashima H, Shirakawa T. Mutation screening of the CARD15 gene in sarcoidosis. Tissue Antigens 71: 564-567 (2008). *

• Akahoshi M, Ishihara M, Remus N, Uno K, Miyake K, Hirota T, Nakashima K, Matsuda A, Kanda M, Enomoto T, Ohno S, Nakashima H, Casanova JL, Hopkin JM, Tamari M, Mao XQ, Shirakawa T. Association between IFNA genotype and the risk of sarcoidosis. Hum. Genet. 114: 503-509 (2004). *

• Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, DeKruyff RH, Umetsu DT. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354: 1117-1129 (2006). *

• Al-Mayouf SM, Al-Sonbul A, Al Jumaah S, Al-Hemidan A. Sarcoidosis: a delayed or missed diagnosis in children. Ann. Saudi Med. 26: 220-223 (2006).

• Aladesanmi OA. Sarcoidosis: an update for the primary care physician. MedGenMed. 6: 7 (2004). *

• Alam I, Levenson SD, Ferrell LD, Bass NM. Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature. Dig. Dis. Sci. 42: 1295-1301 (1997). *

• Alenezi B, Lamoureux E, Alpert L, Szilagyi A. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis. Dig. Dis. Sci. 50: 196-200 (2005). *

• Alexis AF, Strober BE. Off-label dermatologic uses of anti-TNF-a therapies. J. Cutan. Med. Surg. 9: 296-302 (2005). *

• Alia P, Mana J, Capdevila O, Alvarez A, Navarro MA. Association between ACE gene I/D polymorphism and clinical presentation and prognosis of sarcoidosis. Scand. J. Clin. Lab. Invest. 65: 691-698 (2005). *

• Alonso-Llamazares J, Gibson LE, Rogers RS 3rd. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience. Int. J. Dermatol. 46: 910-919 (2007). *

• Amarapurkar DN, Patel ND, Amarapurkar AD. Hepatic sarcoidosis. Indian J. Gastroenterol. 22: 98-100 (2003).

• Anderson CS, Nicholls J, Rowland R, LaBrooy JT. Hepatic granulomas: a 15-year experience in the Royal Adelaide Hospital. Med. J. Aust. 148: 71-74 (1988).

• Ansarian HR, Derakhshan M, Takafuji M, Ihara H. The impact of supramolecular chemistry in medicine: removing the border between infectious and non-infectious diseases. Med. Hypotheses 71: 881-885 (2008).

• Antonelli A, Fazzi P, Fallahi P, Ferrari SM, Grosso M, Boni G, Ferrannini E, Mariani G. Thyroid uptake of (67)Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis. Eur. J. Nucl. Med. Mol. Imaging 36: 137-143 (2009).

• Antoniu SA. Infliximab for the therapy of chronic sarcoidosis, Baughman RP, Drent M, Kavuru M et al.: infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am. J. Respir. Crit. Care Med. (2006) 174(7):795-802. Expert Opin. Investig. Drugs 16: 753-756 (2007).

• Antoniu SA. Targeting the TNF-alpha pathway in sarcoidosis. Expert Opin. Ther. Targets 14: 21-29 (2010).

• Arnett HA, Escobar SS, Gonzalez-Suarez E, Budelsky AL, Steffen LA, Boiani N, Zhang M, Siu G, Brewer AW, Viney JL. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J. Immunol. 178: 1523-1533 (2007). *

• Arostegui JI, Arnal C, Merino R, Modesto C, Antonia Carballo M, Moreno P, Garcia-Consuegra J, Naranjo A, Ramos E, de Paz P, Rius J, Plaza S, Yague J. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum. 56: 3805-3813 (2007). *

• Arostegui JI, Yague J. Hereditary systemic autoinflammatory diseases. Part II: cryopyrin-associated periodic syndromes, pediatric systemic granulomatosis and PAPA syndrome. Med. Clin. (Barc.) 130: 429-438 (2008).

• Asvesti C, Hadziyannis SJ, Papadopoulos S, Giakoumoglou T, Hadziolou E, Trichia E, Zographakis I. Sweat gland carcinoma in a patient with sarcoidosis and primary biliary cirrhosis. Dermatology 189: 198-202 (1994).

• Atzeni F, Doria A, Carrabba M, Turiel M, Sarzi-Puttini P. Potential target of infliximab in autoimmune and inflammatory diseases. Autoimmun. Rev. 6: 529-536 (2007).

• Atzeni F, Sarzi-Puttini P, Doria A, Iaccarino L, Capsoni F. Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review. Autoimmun. Rev. 4: 144-152 (2005).

• Aubart FC, Ouayoun M, Brauner M, Attali P, Kambouchner M, Valeyre D, Nunes H. Sinonasal involvement in sarcoidosis: a case-control study of 20 patients. Medicine (Baltimore) 85: 365-371 (2006).

• Awada H, Abi-Karam G, Fayad F. Musculoskeletal and other extrapulmonary disorders in sarcoidosis. Best Pract. Res. Clin. Rheumatol. 17: 971-987 (2003).

• Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L. The use of tetracyclines for the treatment of sarcoidosis. Arch. Dermatol. 137: 69-73 (2001). *

• Bachmeyer C, Rohaut B. Sarcoidosis mimicking rheumatoid arthritis. Presse. Med. 35: 623-624 (2006).

• Barnes DS. Intrahepatic cholestatic liver disease. http://www.clevelandclinicmeded.com/diseasemanagement/gastro/intrahepatic/intrahepatic1.htm (2002). *

• Barr GD, Shale DJ, Jewell DP. Ulcerative colitis and sarcoidosis. Postgrad. Med. J. 62: 341-345 (1986). *

• Bass NM, Burroughs AK, Scheuer PJ, James DG, Sherlock S. Chronic intrahepatic cholestasis due to sarcoidosis. Gut 23: 417-421 (1982). *

• Basu S, Zhuang H, Torigian DA, Rosenbaum J, Chen W, Alavi A. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin. Nucl. Med. 39: 124-145 (2009).

• Baughman RP, Bradley DA, Lower EE. Infliximab in chronic ocular inflammation. Int. J. Clin. Pharmacol. Ther. 43: 7-11 (2005).

• Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, Albera C, Brutsche M, Davis G, Donohue JF, Muller-Quernheim J, Schlenker-Herceg R, Flavin S, Lo KH, Oemar B, Barnathan ES. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am. J. Respir. Crit. Care Med. 174: 795-802 (2006). *

• Baughman RP, Iannuzzi M. Tumour necrosis factor in sarcoidosis and its potential for targeted therapy. BioDrugs 17: 425-431 (2003).

• Baughman RP, Koehler A, Bejarano PA, Lower EE, Weber FL Jr. Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch. Intern. Med. 163: 615-620 (2003). *

• Baughman RP, Lower EE, Drent M. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them. Sarcoidosis Vasc. Diffuse Lung Dis. 25: 76-89 (2008).

• Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 361: 1111-1118 (2003). *

• Becker CD, Sridhar P, Iannuzzi MC. Cardiac sarcoidosis associated with BTNL2. Cardiology 112: 76-77 (2008).

• Becker H, Maaser C, Mickholz E, Dyong A, Domschke W, Gaubitz M. Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides. Clin. Rheumatol. 25: 368-372 (2006). *

• Becker ML, Martin TM, Doyle TM, Rose CD. Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15. Arthritis Rheum. 56: 1292-1294 (2007). *

• Becker ML, Rose CD. Blau syndrome and related genetic disorders causing childhood arthritis. Curr. Rheumatol. Rep. 7: 427-433 (2005).

• Benbow EW, McMahon RF. Chromolipid-induced portal lymphadenopathy in primary biliary cirrhosis. Histopathology 11: 971-977 (1987).

• Benoit G, Lapeyraque AL, Sartelet H, Saint-Cyr C, Le Deist F, Haddad E. Renal granuloma and immunoglobulin M-complex glomerulonephritis: a case of common variable immunodeficiency? Pediatr. Nephrol. 24: 601-604 (2009).

• Biller H, Zissel G, Ruprecht B, Nauck M, Busse Grawitz A, Muller-Quernheim J. Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur. Respir. J. 28: 1085-1091 (2006).

• Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 131: 524-532 (2007). *

• Blank N, Fiehn C, Lorenz HM. Radiographic healing of sarcoid bone erosion. Z. Rheumatol. 68: 763-765 (2009).

• Blau EB. Familial granulomatous arthritis, iritis, and rash. J. Pediatr. 107: 689-693 (1985).

• Blauwet LA, Cooper LT. Myocarditis. Prog. Cardiovasc. Dis. 52: 274-288 (2010).

• Blich M, Edoute Y. Clinical manifestations of sarcoid liver disease. J. Gastroenterol. Hepatol. 19: 732-737 (2004). *

• Boffetta P, Rabkin CS, Gridley G. A cohort study of cancer among sarcoidosis patients. Int. J. Cancer 124: 2697-2700 (2009). *

• Bogunia-Kubik K, Koscinska K, Suchnicki K, Lange A. HSP70-hom gene single nucleotide (+2763 G/A and +2437 C/T) polymorphisms in sarcoidosis. Int. J. Immunogenet. 33: 135-140 (2006). *

• Bombieri C, Belpinati F, Pignatti PF, Luisetti M. Comment on 'CFTR gene mutations in sarcoidosis'. Eur. J. Hum. Genet. 11: 553-554 (2003). *

• Bombieri C, Benetazzo M, Saccomani A, Belpinati F, Gile LS, Luisetti M, Pignatti PF. Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease. Hum. Genet. 103: 718-722 (1998). *

• Bombieri C, Luisetti M, Belpinati F, Zuliani E, Beretta A, Baccheschi J, Casali L, Pignatti PF. Increased frequency of CFTR gene mutations in sarcoidosis: a case/control association study. Eur. J. Hum. Genet. 8: 717-720 (2000). *

• Bonfioli AA, Damico FM, Curi AL, Orefice F. Intermediate uveitis. Semin. Ophthalmol. 20: 147-154 (2005).

• Bonnet F, Dubuc J, Morlat P, Delbrel X, Doutre MS, de Witte S, Bernard N, Lacoste D, Longy-Boursier M, Beylot J. Sarcoidosis and comorbidity: retrospective study of 32 cases. Rev. Med. Interne. 22: 619-623 (2001).

• Borchers AT, So C, Naguwa SM, Keen CL, Gershwin ME. Clinical and immunologic components of sarcoidosis. Clin. Rev. Allergy Immunol. 25: 289-303 (2003).

• Borges da Costa J, Mayer-da-Silva A, Soares de Almeida LM, Marques Gomes M. Success of prednisone in the treatment of a patient with sarcoidosis and systemic sclerosis: report of a case. Dermatol. Online J. 15: 11 (2009). *

• Bories C, Certin M, Lavergne A, Galian A, Godeau P, Rambaud JC. Primary biliary cirrhosis and sarcoidosis. Association or unique disease? Gastroenterol. Clin. Biol. 8: 851-855 (1984).

• Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F. NOD2-associated diseases: bridging innate immunity and autoinflammation. Clin. Immunol. May 23 [Epub ahead of print] (2009). *

• Bourhis LL, Benko S, Girardin SE. Nod1 and Nod2 in innate immunity and human inflammatory disorders. Biochem. Soc. Trans. 35: 1479-1484 (2007). *

• Brandt D, Gershwin ME. Common variable immune deficiency and autoimmunity. Autoimmun. Rev. 5: 465-470 (2006).

• Brewerton DA. Discovery: HLA and disease. Curr. Opin. Rheumatol. 15: 369-373 (2003).

• Bronner MP. Granulomatous appendicitis and the appendix in idiopathic inflammatory bowel disease. Semin. Diagn. Pathol. 21: 98-107 (2004).

• Brown JJ, Ollier WE, Thomson W, Bayat A. Positive association of HLA-DRB1*15 with keloid disease in Caucasians. Int. J. Immunogenet. 35: 303-307 (2008). *

• Bruguera M, Llach J, Rodes J. Nonsyndromic paucity of intrahepatic bile ducts in infancy and idiopathic ductopenia in adulthood: the same syndrome? Hepatology 15: 830-834 (1992).

• Brunner J, Sergi C, Muller T, Gassner I, Prufer F, Zimmerhackl LB. Juvenile sarcoidosis presenting as Crohn's disease. Eur. J. Pediatr. 165: 398-401 (2006). *

• Burke ML, Jones MK, Gobert GN, Li YS, Ellis MK, McManus DP. Immunopathogenesis of human schistosomiasis. Parasite Immunol. 31: 163-176 (2009). *

• Burnevich EZ, Lopatkina TN. System manifestations of primary biliary cirrhosis. Klin. Med. (Mosk.) 84: 42-46 (2006).

• Burns TM. Neurosarcoidosis. Arch. Neurol. 60: 1166-1168 (2003).

• Calabuig E, Salavert M. Infectious risk. Actas Dermosifiliogr. 99 Suppl. 4: 14-22 (2008).

• Caldwell SH, Leung PS, Spivey JR, Prindiville T, de Medina M, Saicheur T, Rowley M, Reddy KR, Coppel R, Jeffers LJ, et al. Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members. Hepatology 16: 899-905 (1992).

• Callejas-Rubio JL, Lopez-Perez L, Ortego-Centeno N. Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis. Ther. Clin. Risk Manag. 4: 1305-1213 (2008). *

• Campo I, Morbini P, Zorzetto M, Tinelli C, Brunetta E, Villa C, Bombieri C, Cuccia M, Agostini C, Bozzi V, Facoetti A, Ferrarotti I, Mazzola P, Scabini R, Semenzato G, Pignatti PF, Pozzi E, Luisetti M. Expression of receptor for advanced glycation end products in sarcoid granulomas. Am. J. Respir. Crit. Care Med. 175: 498-506 (2007). *

• Capelli A, Di Stefano A, Gnemmi I, Donner CF. CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis. Eur. Respir. J. 25: 701-707 (2005). *

• Capron JP. Non-cirrhotic intrahepatic portal hypertension. Rev. Prat. 40: 1473-1478 (1990).

• Carlson JA, Chen KR. Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes. Am. J. Dermatopathol. 29: 32-43 (2007).

• Carpinteri R, Patelli I, Casanueva FF, Giustina A. Inflammatory and granulomatous expansive lesions of the pituitary. Best Pract. Res. Clin. Endocrinol. Metab. 23: 639-650 (2009).

• Cathebras PJ, Mosnier JF, Gouilloud S, Bouchou K, Rousset H. Hepatic granulomatosis in a patient with Graves' disease. Eur. J. Gastroenterol. Hepatol. 7: 905-908 (1995).

• Cather JC, Cohen PR. Ichthyosiform sarcoidosis. J. Am. Acad. Dermatol. 40: 862-865 (1999).

• Chapelon-Abric C. Epidemiology of sarcoidosis and its genetic and environmental risk factors. Rev. Med. Interne. 25: 494-500 (2004).

• Chatham W. Rheumatic manifestations of systemic disease: sarcoidosis. Curr. Opin. Rheumatol. 22: 85-90 (2010).

• Chawla Y, Dhiman RK. Intrahepatic portal venopathy and related disorders of the liver. Semin. Liver Dis. 28: 270-281 (2008).

• Chazouilleres O. Chronic cholestatic disorders in the adult. Pathol. Biol. (Paris) 47: 974-982 (1999).

• Concheiro Cao J, Loureiro Martinez M, Tarrazo Antelo M, Lado Lado FL. Extrapulmonary sarcoidosis as a cause of chronic liver disease. Report of one case. An. Med. Interna 23: 48-49 (2006).

• Costabel U. Sarcoidosis: clinical update. Eur. Respir. J. Suppl. 32: 56s-68s (2001). *

• Costabel U, Guzman J. Pulmonary alveolar proteinosis: a new autoimmune disease. Sarcoidosis Vasc. Diffuse Lung Dis. 22 Suppl. 1:S67-S73 (2005).

• Coto-Segura P, Mallo-Garcia S, Costa-Romero M, Arostegui JI, Yague J, Ramos-Polo E, Santos-Juanes J. A sporadic case of early-onset sarcoidosis resembling Blau syndrome due to the recurrent R334W missense mutation on the NOD2 gene. Br. J. Dermatol. 157: 1257-1259 (2007). *

• Couderc LJ, Catherinot E. Sarcoidosis and granulomatous disease: observation. Rev. Mal. Respir. 23: 5S59-5S67 (2006).

• Covic A, Mutica C, Ignat A, Boaru I, Veisa G, Gusbeth-Tatomir P, Enea M, Covic M. Retrospective study of 97 ANCA-positive patients: epidemiological and clinical spectrum. Rev. Med. Chir. Soc. Med. Nat. Iasi. 108: 305-310 (2004).

• Cox CE, Davis-Allen A, Judson MA. Sarcoidosis. Med. Clin. North Am. 89: 817-828 (2005).

• Crothers K, Huang L. Pulmonary complications of immune reconstitution inflammatory syndromes in HIV-infected patients. Respirology 14: 486-494 (2009).

• Culver DA, Newman LS, Kavuru MS. Gene-environment interactions in sarcoidosis: challenge and opportunity. Clin. Dermatol. 25: 267-275 (2007).

• Culver DA, Thomassen MJ, Kavuru MS. Pulmonary sarcoidosis: new genetic clues and ongoing treatment controversies. Cleve. Clin. J. Med. 71: 88, 90, 92 (2004). *

• Cunnigham D, Mills PR, Quigley EM, Patrick RS, Watkinson G, MacKenzie JF, Russell RI. Hepatic granulomas: experience over a 10-year period in the West of Scotland. Q. J. Med. 51: 162-170 (1982).

• Czaja AJ. Autoimmune liver disease and rheumatic manifestations. Curr. Opin. Rheumatol. 19: 74-80 (2007).

• Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 23: 255-262 (2007).

• Dahdah MJ, Kurban M, Kibbi AG, Ghosn S. Primary localized cutaneous amyloidosis: a sign of immune dysregulation? Int. J. Dermatol. 48: 419-421 (2009).

• Daien CI, Monnier A, Claudepierre P, Constantin A, Eschard JP, Houvenagel E, Samimi M, Pavy S, Pertuiset E, Toussirot E, Combe B, Morel J; for the Club Rhumatismes et Inflammation (CRI). Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford) 48: 883-886 (2009).

• Daoud L, El Euch D, Ben Tekaya N, Cherif F, Mokni M, Ben Osman A. Erythema nodosum: profile in a Tunisian teaching hospital. Tunis. Med. 85: 1020-1024 (2007).

• Dash SS, Malhotra AK, Bhatti SS, Karak AK, Gupta S. Discoid lupus erythematosus-like sarcoidosis. Clin. Exp. Dermatol. 32: 442-443 (2007). *

• de Jager M, Blokx W, Warris A, Bergers M, Link M, Weemaes C, Seyger M. Immunohistochemical features of cutaneous granulomas in primary immunodeficiency disorders: a comparison with cutaneous sarcoidosis. J. Cutan. Pathol. 35: 467-472 (2008).

• De Quatrebarbes J, Cordel N, Bravard P, Lenormand B, Joly P. Miescher's cheilitis and lymphocytic clonal expansion: 2 cases. Ann. Dermatol. Venereol. 131: 55-57 (2004).

• De Vries J, Michielsen H, Van Heck GL, Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br. J. Health Psychol. 9: 279-291 (2004).

• Delfosse V, de Leval L, De Roover A, Delwaide J, Honore P, Boniver J, Detry O. Budd-Chiari syndrome complicating hepatic sarcoidosis: definitive treatment by liver transplantation: a case report. Transplant. Proc. 41: 3432-3434 (2009). *

• Demirkok SS, Arzuhal N, Devranoglu G, Demirkesen C, Tuzun Y. Recurrent sarcoidosis on a scar associated with vitiligo. J. Dermatol. 34: 829-833 (2007).

• Demirkok SS, Basaranoglu M, Akinci ED, Karayel T. Analysis of 275 patients with sarcoidosis over a 38 year period; a single-institution experience. Respir. Med. 101: 1147-1154 (2007).

• Deniz K, Ward SC, Rosen A, Grewal P, Xu R. Budd-Chiari syndrome in sarcoidosis involving liver. Liver Int. 28: 580-581 (2008). *

• Denning GM, Stoll LL. Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease? Pediatr. Pulmonol. 41: 23-34 (2006).

• Denys BG, Bogaerts Y, Coenegrachts KL, De Vriese AS. Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer? Clin. Sci. (Lond.) 112: 281-289 (2007). *

• Desmet VJ. Destructive intrahepatic bile duct diseases. Recenti Prog. Med. 81: 392-398 (1990).

• Devaney K, Goodman ZD, Epstein MS, Zimmerman HJ, Ishak KG. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am. J. Surg. Pathol. 17: 1272-1280 (1993).

• Dinic-Uzurov V, Lalosevic V, Milosevic I, Urosevic I, Lalosevic D, Popovic S. Current differential diagnosis of hypereosinophilic syndrome. Med. Pregl. 60: 581-586 (2007).

• Dobbin CJ, Moriarty C, Bye PT. Granulomatous diseases in a patient with cystic fibrosis. J. Cyst. Fibros. 2: 35-37 (2003).

• Domiciano DS, Carvalho JF, Shoenfeld Y. Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases. Lupus 18: 1233-1238 (2009).

• Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest 127: 1064-1071 (2005). *

• Dourakis SP, Saramadou R, Alexopoulou A, Kafiri G, Deutsch M, Koskinas J, Archimandritis AJ. Hepatic granulomas: a 6-year experience in a single center in Greece. Eur. J. Gastroenterol. Hepatol. 19: 101-104 (2007).

• Doycheva D, Deuter C, Stuebiger N, Zierhut M. Interferon-alpha-associated presumed ocular sarcoidosis. Graefes Arch. Clin. Exp. Ophthalmol. 247: 675-680 (2009). *

• Doyle MK, Berggren R, Magnus JH. Interferon-induced sarcoidosis. J. Clin. Rheumatol. 12: 241-248 (2006).

• Drebber U, Kasper HU, Ratering J, Wedemeyer I, Schirmacher P, Dienes HP, Odenthal M. Hepatic granulomas: histological and molecular pathological approach to differential diagnosis-a study of 442 cases. Liver Int. 28: 828-834 (2008).

• Drent M, van den Berg R, Haenen GR, van den Berg H, Wouters EF, Bast A. NF-kappaB activation in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 18: 50-56 (2001).

• du Bois RM, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J. Intern. Med. 253: 4-17 (2003). *

• Du L, Kijlstra A, Yang P. Immune response genes in uveitis. Ocul. Immunol. Inflamm. 17: 249-256 (2009).

• Dubaniewicz A. Mycobacterium tuberclosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmun. Rev. Nov 18 [Epub ahead of print] (2009).

• Dubaniewicz A, Dubaniewicz-Wybieralska M, Moszkowska G, Sternau A, Dubaniewicz A. Comparative analysis of DR and DQ alleles occurrence in sarcoidosis and tuberculosis in the same ethnic group: preliminary study. Sarcoidosis Vasc. Diffuse Lung Dis. 23: 180-189 (2006).

• Dubaniewicz A, Jamieson SE, Dubaniewicz-Wybieralska M, Fakiola M, Nancy Miller E, Blackwell JM. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland. Eur. J. Hum. Genet. 13: 829-834 (2005). *

• Dubaniewicz A, Szczerkowska Z, Hoppe A. Comparative analysis of HLA class I antigens in pulmonary sarcoidosis and tuberculosis in the same ethnic group. Mayo Clin. Proc. 78: 436-442 (2003). *

• Duet M, Liote F. Somatostatin and somatostatin analog scintigraphy: any benefits for rheumatology patients? Joint Bone Spine 71: 530-535 (2004).

• Duna GF, Cotch MF, Galperin C, Hoffman DB, Hoffman GS. Wegener's granulomatosis: role of environmental exposures. Clin. Exp. Rheumatol. 16: 669-674 (1998).

• Duzova A, Bakkaloglu A. Central nervous system involvement in pediatric rheumatic diseases: current concepts in treatment. Curr. Pharm. Des. 14: 1295-1301 (2008).

• Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. Am. J. Gastroenterol. 103: 3184-3192 (2008). *

• Efthimiou P, Markenson JA. Role of biological agents in immune-mediated inflammatory diseases. South. Med. J. 98: 192-204 (2005).

• Eishi Y. Seeking a causative agent of sarcoidosis. Nippon Rinsho 52: 1486-1491 (1994).

• Eklund A, Stjernberg N, Uddenfeldt P, Danielsson A. Kveim test and mitochondrial antibodies in the differential diagnosis between primary biliary cirrhosis and sarcoidosis. Sarcoidosis 2: 38-41 (1985).

• Ekstrom Smedby K, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjose S, Chiu BC, Dal Maso L, Cocco P, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111: 4029-4038 (2008). *

• el-Zaatari FA, Naser SA, Markesich DC, Kalter DC, Engstand L, Graham DY. Identification of Mycobacterium avium complex in sarcoidosis. J. Clin. Microbiol. 34: 2240-2245 (1996). *

• Emanuel PO, Phelps RG. Metastatic Crohn's disease: a histopathologic study of 12 cases. J. Cutan. Pathol. 35: 457-461 (2008). *

• Enzenauer RJ, West SG. Sarcoidosis in autoimmune disease. Semin. Arthritis Rheum. 22: 1-17 (1992).

• Ezzie ME, Crouser ED. Considering an infectious etiology of sarcoidosis. Clin. Dermatol. 25: 259-266 (2007).

• Fadil H, Kelley RE, Gonzalez-Toledo E. Differential diagnosis of multiple sclerosis. Int. Rev. Neurobiol. 79C: 393-422 (2007).

• Fan C, Nylander PO, Sikstrom C, Thunell M. Orosomucoid and haptoglobin types in patients with sarcoidosis. Exp. Clin. Immunogenet. 12: 31-35 (1995).

• Fauroux B, Clement A. Paediatric sarcoidosis. Paediatr. Respir. Rev. 6: 128-133 (2005).

• Ferguson MM, MacFadyen EE. Orofacial granulomatosis - a 10 year review. Ann. Acad. Med. Singapore 15: 370-377 (1986).

• Ferlitsch A, Kummer F, Muller MM, Legenstein E, Haber P, Kohout J. Angiotensin converting enzyme (ACE) - a blood chemistry parameter in the diagnosis of sarcoidosis. Acta Med. Austriaca 5: 171-174 (1978).

• Fernandez-Faith E, McDonnell J. Cutaneous sarcoidosis: differential diagnosis. Clin. Dermatol. 25: 276-287 (2007).

• Finsterer J. Systemic and non-systemic vasculitis affecting the peripheral nerves. Acta Neurol. Belg. 109: 100-113 (2009).

• Fite E, Fernandez-Figueras MT, Prats R, Vaquero M, Morera J. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration 73: 20-26 (2006). *

• Foley PJ, McGrath DS, Puscinska E, Petrek M, Kolek V, Drabek J, Lympany PA, Pantelidis P, Welsh KI, Zielinski J, du Bois RM. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am. J. Respir. Cell. Mol. Biol. 25: 272-277 (2001). *

• Foley PJ, Mullighan CG, McGrath DS, Pantelidis P, Marshall S, Lympany PA, Welsh KI, du Bois RM. Mannose-binding lectin promoter and structural gene variants in sarcoidosis. Eur. J. Clin. Invest. 30: 549-552 (2000). *

• Forde AM, Feighery C, Jackson J. Anti-monocyte cytoplasmic antibodies in granulomatous disease. Clin. Immunol. Immunopathol. 81: 88-95 (1996). *

• Forde AM, Feighery C, Jackson J. Characterisation of anti-neutrophil cytoplasmic antibody target antigens using electrophoresis and western blotting techniques. Br. J. Biomed. Sci. 55: 247-252 (1998).

• Foschini MP, Macchia S, Losi L, Dei Tos AP, Pasquinelli G, Di Tommaso L, Del Duca S, Roncaroli F, Dal Monte PR. Identification of mitochondria in liver biopsies. A study by immunohistochemistry, immunogold and Western blot analysis. Virchows. Arch. 433: 267-273 (1998). *

• Franco J, Saeian K. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis. Curr. Gastroenterol. Rep. 1: 95-101 (1999).

• Franke A, Fischer A, Nothnagel M, Becker C, Grabe N, Till A, Lu T, Muller Quernheim J, Wittig M, Hermann A, Balschun T, Hofmann S, Niemiec R, Schulz S, Hampe J, Nikolaus S, Nurnberg P, Krawczak M, Schurmann M, Rosenstiel P, Nebel A, Schreiber S. Genome-wide association analysis in sarcoidosis and Crohn disease unravels a common susceptibility locus on 10p12.2. Gastroenterology 135: 1207-1215 (2008). *

• French MA. Immune reconstitution inflammatory syndrome: a reappraisal. Clin. Infect. Dis. 48: 101-107 (2009). *

• Frieri M. Identification of masqueraders of autoimmune disease in the office. Allergy Asthma Proc. 24: 421-429 (2003).

• Froidure A, Horsmans Y, Lefebvre C. Multisystemic sarcoidosis associated with a second therapy for chronic hepatitis C. Acta Gastroenterol. Belg. 72: 249-251 (2009).

• Fuentes-Paez G, Martinez-Osorio H, Herreras JM, Calonge M. Subretinal fibrosis and uveitis syndrome associated with ulcerative colitis. Int. J. Colorectal Dis. 22: 333-334 (2007). *

• Fuertes I, Espinosa G, Ramos-Casals M, Cervera R. Association of Sjogren syndrome, autoimmune thyroiditis, sarcoidosis, primary biliary cirrhosis and primary amyloidosis in a single patient. Rev. Clin. Esp. 207: 376 (2007).

• Furlan A, Podswiadek M, Cozzi F, Todesco S. Tenosynovitis of the ankles as onset of sarcoidosis in a patient with ulcerative colitis. Reumatismo 57: 197-200 (2005).

• Furukawa A, Uchida K, Ishige Y, Ishige I, Kobayashi I, Takemura T, Yokoyama T, Iwai K, Watanabe K, Shimizu S, Ishida N, Suzuki Y, Suzuki T, Yamada T, Ito T, Eishi Y. Characterization of Propionibacterium acnes isolates from sarcoid and non-sarcoid tissues with special reference to cell invasiveness, serotype, and trigger factor gene polymorphism. Microb. Pathog. 46: 80-87 (2009). *

• Garcia-Zuazaga J, Korman NJ. Cutaneous sarcoidosis successfully treated with alefacept. J. Cutan. Med. Surg. 10: 300-303 (2006).

• Garg S, Garg K, Altaf M, Magaldi JA. Refractory vertebral sarcoidosis responding to infliximab. J. Clin. Rheumatol. 14: 238-240 (2008).

• Gary A, Modeste AB, Richard C, Jubert C, Majour F, Nouvet G, Remond B, Joly P. Methotrexate for the treatment of patients with chronic cutaneous sarcoidosis: 4 cases. Ann. Dermatol. Venereol. 132: 659-662 (2005).

• Gaya DR, Thorburn D, Oien KA, Morris AJ, Stanley AJ. Hepatic granulomas: a 10 year single centre experience. J. Clin. Pathol. 56: 850-853 (2003). *

• Gazouli M, Koundourakis A, Ikonomopoulos J, Gialafos EJ, Rapti A, Gorgoulis VG, Kittas C. CARD15/NOD2, CD14, and Toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 23: 23-29 (2006).

• Gdynia HJ, Mogel H, Kuhnlein P, Dorst J, Osterfeld N, von Arnim CA, Sperfeld AD. Diagnosis and differential diagnosis of granulomatous myositis. Nervenarzt. 79: 470-474 (2008).

• Gheith O, Al-Otaibi T, Tawab KA, Said T, Balaha MA, Halim MA, Nair MP, Nampoory MR. Erythema nodosum in renal transplant recipients: multiple cases and review of literature. Transpl. Infect. Dis. Dec 14 [Epub ahead of print] (2009).

• Ghirardello S, Garre ML, Rossi A, Maghnie M. The diagnosis of children with central diabetes insipidus. J. Pediatr. Endocrinol. Metab. 20: 359-375 (2007). *

• Giovinale M, Fonnesu C, Soriano A, Cerquaglia C, Curigliano V, Verrecchia E, De Socio G, Gasbarrini G, Manna R. Atypical sarcoidosis: case reports and review of the literature. Eur. Rev. Med. Pharmacol. Sci. 13 Suppl. 1: 37-44 (2009).

• Giuffrida TJ, Kerdel FA. Sarcoidosis. Dermatol. Clin. 20: 435-447, vi (2002).

• Glynn F, O'Sullivan P. Vocal fold deposits in macrophagic myofasciitis. Ear Nose Throat J. 86: 238-239 (2007).

• Goljan A, Puscinska E, Zych D, Zielinski J. Familial sarcoidosis in Poland: analysis of clinical characteristics and environmental aspects. Pneumonol. Alergol. Pol. 68: 510-522 (2000).

• Gordon JN, Sabatino AD, Macdonald TT. The pathophysiologic rationale for biological therapies in inflammatory bowel disease. Curr. Opin. Gastroenterol. 21: 431-437 (2005).

• Gordon LK. Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye 20: 1196-1206 (2006).

• Goto M, Koyama H, Takahashi O, Fukui T. A retrospective review of 226 hospitalized patients with fever. Intern. Med. 46: 17-22 (2007). *

• Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Anaya JM, Sibilia J, Mariette X. Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann. Rheum. Dis. 64: 913-920 (2005). *

• Gottlieb C, Li Z, Uzel G, Nussenblatt RB, Sen HN. Uveitis in DiGeorge syndrome: a case of autoimmune ocular inflammation in a patient with deletion 22q11.2. Ophthalmic Genet. 31: 24-29 (2010).

• Granata F, Nardicchi V, Loffredo S, Frattini A, Ilaria Staiano R, Agostini C, Triggiani M. Secreted phospholipases A(2): a proinflammatory connection between macrophages and mast cells in the human lung. Immunobiology 214: 811-821 (2009).

• Grant WB, Garland CF. The health benefits of vitamin D greatly outweigh the health risks. Bioessays 30: 506-507 (2008). *

• Gras M, van Kemenade FJ, van Maarsseveen AC, Alberts C. Sarcoidosis: immunopathogenesis and the potential of immunotherapy. Ned. Tijdschr. Geneeskd. 147: 150-155 (2003).

• Grave B, McCullough M, Wiesenfeld D. Orofacial granulomatosis - a 20-year review. Oral Dis. 15: 46-51 (2009).

• Gray-McGuire C, Sinha R, Iyengar S, Millard C, Rybicki BA, Elston RC, Iannuzzi MC; SAGA Study Consortium. Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum. Genet. 120: 420-430 (2006). *

• Greim B, Engel C, Apel A, Zettl UK. Fatigue in neuroimmunological diseases. J. Neurol. 254 Suppl. 2: II102-II106 (2007).

• Grenier PA, Beigelman-Aubry C, Brillet PY. Nonneoplastic tracheal and bronchial stenoses. Radiol. Clin. North Am. 47: 243-260 (2009).

• Gronhagen-Riska C, Fyhrquist F, Hortling L, Koskimies S. Familial occurrence of sarcoidosis and Crohn's disease. Lancet 1: 1287-1288 (1983).

• Grubic Z, Zunec R, Peros-Golubicic T, Tekavec-Trkanjec J, Martinez N, Alilovic M, Smojver-Jezek S, Kerhin-Brkljacic V. HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, -DRB1*0301, and -DQB1*0201 haplotype in clinical variations of the disease. Tissue Antigens 70: 301-306 (2007). *

• Grunewald J. Genetics of sarcoidosis. Curr. Opin. Pulm. Med. 14: 434-439 (2008).

• Grunewald J, Eklund A. State of the art. Role of CD4+ T cells in sarcoidosis. Proc. Am. Thorac. Soc. 4: 461-464 (2007). *

• Grunewald J, Eklund A. Gender specific manifestations of Lofgren's syndrome. Am. J. Respir. Crit. Care Med. 175: 40-44 (2007). *

• Grunewald J, Eklund A. Lofgren's syndrome: human leukocyte antigen strongly influence the disease course. Am. J. Respir. Crit. Care Med. 179: 307-312 (2009). *

• Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am. J. Respir. Crit. Care Med. 169: 696-702 (2004). *

• Grunewald J, Olerup O, Persson U, Ohrn MB, Wigzell H, Eklund A. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc. Natl. Acad. Sci. U.S.A. 91: 4965-4969 (1994). *

• Grunhage F, Spengler U, Fischer HP, Sauerbruch T. Autoimmune hepatitis - sequel of a relapsing hepatitis A in a 75-year-old woman. Digestion 70: 187-191 (2004).

• Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J. Cutan. Med. Surg. 8: 77-89 (2004). *

• Gur C, Lalazar G, Doviner V, Fridlender ZG, Molcho V, Abu-Much S, Shalit M, Elinav E. Late-onset sarcoidosis after liver transplantation for primary biliary cirrhosis. J. Clin. Gastroenterol. 41: 329-332 (2007).

• Haley H, Cantrell W, Smith K. Infliximab therapy for sarcoidosis (lupus pernio). Br. J. Dermatol. 150: 146-149 (2004). *

• Handa T, Nagai S, Ito I, Shigematsu M, Hamada K, Kitaichi M, Izumi T, Mishima M. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism affects lymphocyte profiles in bronchoalveolar lavage of patients with sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 20: 190-196 (2003).

• Handa T, Nagai S, Ito I, Tabuena R, Shigematsu M, Hamada K, Kitaichi M, Izumi T, Aoyama T, Toguchida J, Mishima M. Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis. Respiration 72: 243-248 (2005). *

• Haraoui B. Differentiating the efficacy of the tumor necrosis factor inhibitors. Semin. Arthritis Rheum. 34: 7-11 (2005). *

• Haraoui B. Differentiating the efficacy of tumor necrosis factor inhibitors. J. Rheumatol. Suppl. 74: 3-7 (2005).

• Harrington AC, Fitzpatrick JE. Cutaneous sarcoidal granulomas in a patient with primary biliary cirrhosis. Cutis 49: 271-274 (1992).

• Hashkes PJ, Shajrawi I. Sarcoid-related uveitis occurring during etanercept therapy. Clin. Exp. Rheumatol. 21: 645-646 (2003).

• Hata M, Sugisaki K, Miyazaki E, Kumamoto T, Tsuda T. Circulating IL-12 p40 is increased in the patients with sarcoidosis, correlation with clinical markers. Intern. Med. 46: 1387-1393 (2007). *

• Hattori N, Niimi T, Sato S, Achiwa H, Maeda H, Oguri T, Bessho Y, Ito H, Shimizu S, Ueda R. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients. Sarcoidosis Vasc. Diffuse Lung Dis. 22: 27-32 (2005).

• Hawryluk EB, Izikson L, English JC 3rd. Non-infectious granulomatous diseases of the skin and their associated systemic diseases: an evidence-based update to important clinical questions. Am. J. Clin. Dermatol. Feb 25 [Epub ahead of print] (2010).

• Hayashi T, Nakamura T, Kurachi K, Asai Y, Nakajima A, Suzuki S, Konno H. Ulcerative colitis accompanied with sarcoidosis and dermatomyositis: report of a case. Dis. Colon Rectum 51: 474-476 (2008). *

• Healy PJ, Helliwell PS. Dactylitis: pathogenesis and clinical considerations. Curr. Rheumatol. Rep. 8: 338-341 (2006).

• Heffner DK. The cause of sarcoidosis: the centurial enigma solved. Ann. Diagn. Pathol. 11: 142-152 (2007).

• Heijckmann AC, Dumitrescu B, Nieuwenhuijzen Kruseman AC, Geusens P, Wolffenbuttel BH, De Vries J, Drent M, Huijberts MS. Quantitative ultrasound does not identify patients with an inflammatory disease at risk of vertebral deformities. BMC Musculoskelet. Disord. 9: 72 (2008). *

• Hemminki K, Li X, Sundquist J, Sundquist K. Familial association between type 1 diabetes and other autoimmune and related diseases. Diabetologia 52: 1820-1828 (2009). *

• Hemminki K, Li X, Sundquist J, Sundquist K. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum. 60: 661-668 (2009). *

• Hemminki K, Li X, Sundquist K, Sundquist J. Familial association of inflammatory bowel diseases with other autoimmune and related diseases. Am. J. Gastroenterol. 105: 139-147 (2010). *

• Henckaerts L, Vermeire S. NOD2/CARD15 disease associations other than Crohn's disease. Inflamm. Bowel Dis. 13: 235-241 (2007). *

• Heron M, Grutters JC, van Moorsel CH, Ruven HJ, Huizinga TW, van der Helm-van Mil AH, Claessen AM, van den Bosch JM. Variation in IL7R predisposes to sarcoid inflammation. Genes Immun. 10: 647-653 (2009).

• Heron M, Grutters JC, Van Moorsel CH, Ruven HJ, Kazemier KM, Claessen AM, Van den Bosch JM. Effect of variation in ITGAE on risk of sarcoidosis, CD103 expression, and chest radiography. Clin. Immunol. 133: 117-125 (2009). *

• Herrmann DN, Blaivas M, Wald JJ, Feldman EL. Granulomatous myositis, primary biliary cirrhosis, pancytopenia, and thymoma. Muscle Nerve 23: 1133-1136 (2000). *

• Hewison M. Vitamin D and the intracrinology of innate immunity. Mol. Cell. Endocrinol. Feb 12 [Epub ahead of print] (2010).

• Hill MR, Papafili A, Booth H, Lawson PJ, Hubner M, Beynon H, Read C, Lindahl G, Marshall RP, McAnulty RJ, Laurent GJ. Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am. J. Respir. Crit. Care Med. 174: 915-922 (2006). *

• Hilzenrat N, Spanier A, Lamoureux E, Bloom C, Sherker A. Colonic obstruction secondary to sarcoidosis: nonsurgical diagnosis and management. Gastroenterology 108: 1556-1559 (1995). *

• Hines ME 2nd, Styer EL. Preliminary characterization of chemically generated Mycobacterium avium subsp. paratuberculosis cell wall deficient forms (spheroplasts). Vet. Microbiol. 95: 247-258 (2003). *

• Hiramatsu J, Kataoka M, Nakata Y, Okazaki K, Tada S, Tanimoto M, Eishi Y. Propionibacterium acnes DNA detected in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 20: 197-203 (2003).

• Ho LP, Merlin F, Gaber K, Davies RJ, McMichael AJ, Hugot JP. CARD 15 gene mutations in sarcoidosis. Thorax 60: 354-355 (2005). *

• Hobson-Webb LD, Donofrio PD. Inflammatory neuropathies: an update on evaluation and treatment. Curr. Rheumatol. Rep. 7: 348-355 (2005).

• Hoefnagels MA, van Leusen R, de Vries RA. Three patients with weight loss as a result of sarcoidosis presenting as liver disease. Ned. Tijdschr. Geneeskd. 147: 2453-2457 (2003).

• Hoffmann R, Germann EJ, Schmidt U, Jenss H. Primary biliary liver cirrhosis and granulomatous pulmonary infiltrates. Schweiz. Med. Wochenschr. 116: 1098-1102 (1986).

• Hofmann S, Franke A, Fischer A, Jacobs G, Nothnagel M, Gaede KI, Schurmann M, Muller-Quernheim J, Krawczak M, Rosenstiel P, Schreiber S. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat. Genet. 40: 1103-1106 (2008). *

• Homma JY, Abe C, Chosa H, Ueda K, Saegusa J, Nakayama M, Homma H, Washizaki M, Okano H. Bacteriological investigation on biopsy specimens from patients with sarcoidosis. Jpn. J. Exp. Med. 48: 251-255 (1978).

• Howarth PH, Babu KS, Arshad HS, Lau LC, Buckley MG, McConnell W, Beckett P, Ali MA, Chauhan A, Wilson SJ, Reynolds A, Davies DE, Holgate ST. Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid-dependent asthma. Thorax 60: 1012-1018 (2005). *

• Hviid TV, Milman N, Hylenius S, Jakobsen K, Jensen MS, Larsen LG. HLA-G polymorphisms and HLA-G expression in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 23: 30-37 (2006).

• Hwang E, McBride R, Neugut AI, Green PH. Sarcoidosis in patients with celiac disease. Dig. Dis. Sci. 53: 977-981 (2008). *

• Iannuzzi MC. Thomas A. Neff lecture. Advances in the genetics of sarcoidosis. Proc. Am. Thorac. Soc. 4: 457-460 (2007). *

• Iannuzzi MC. Genetics of sarcoidosis. Semin. Respir. Crit. Care Med. 28: 15-21 (2007).

• Iannuzzi MC, Iyengar SK, Gray-McGuire C, Elston RC, Baughman RP, Donohue JF, Hirst K, Judson MA, Kavuru MS, Maliarik MJ, Moller DR, Newman LS, Rabin DL, Rose CS, Rossman MD, Teirstein AS, Rybicki BA. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun. 6: 509-518 (2005). *

• Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am. J. Respir. Crit. Care Med. 167: 1225-1231 (2003). *

• Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N. Engl. J. Med. 357: 2153-2165 (2007). *

• Iglesias Alzueta J, Matamoros Florí N. Common variable immunodeficiency. Review. Allergol. Immunopathol. (Madr.) 29: 113-118 (2001).

• Ikonomopoulos JA, Gorgoulis VG, Kastrinakis NG, Zacharatos PV, Kokotas SN, Evangelou K, Kotsinas AG, Tsakris AG, Manolis EN, Kittas CN. Sensitive differential detection of genetically related mycobacterial pathogens in archival material. Am. J. Clin. Pathol. 114: 940-950 (2000). *

• Ilan Y, Rappaport I, Feigin R, Ben-Chetrit E. Primary sclerosing cholangitis in sarcoidosis. J. Clin. Gastroenterol. 16: 326-328 (1993).

• Inui N, Matsui T, Suda T, Chida K. Anti-endothelial cell antibodies in patients with sarcoidosis. Chest 133: 955-960 (2008). *

• Irie T, Maeda Y, Aida T, Sumitani K, Nagumo M, Tachikawa T. Multiple granulomatous inflammation in the minor salivary glands: a proposed new entity, allergic granulomatous sialadenitis. Pathol. Int. 54: 850-853 (2004). *

• Isern V, Lora-Tamayo J, Capdevila O, Villabona C, Mana J. Sarcoidosis and autoimmune thyroid disease. A case series of ten patients. Sarcoidosis Vasc. Diffuse Lung Dis. 24: 148-152 (2007).

• Ishak KG. Sarcoidosis of the liver and bile ducts. Mayo Clin. Proc. 73: 467-472 (1998). *

• Ishige I, Eishi Y, Takemura T, Kobayashi I, Nakata K, Tanaka I, Nagaoka S, Iwai K, Watanabe K, Takizawa T, Koike M. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 22: 33-42 (2005).

• Ishihara M, Ishida T, Inoko H, Ando H, Naruse T, Nose Y, Ohno S. HLA serological and class II genotyping in sarcoidosis patients in Japan. Jpn. J. Ophthalmol. 40: 86-94 (1996).

• Ishihara M, Ohno S. Genetic influences on sarcoidosis. Eye 11: 155-161 (1997).

• Ishihara M, Ohno S, Ishida T, Ando H, Naruse T, Nose Y, Inoko H. Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens 43: 238-241 (1994).

• Ishihara M, Ohno S, Ishida T, Naruse T, Inoko H. Genetic polymorphism in intron 6 of the LMP7 gene in Japanese and its association with sarcoidosis. Tissue Antigens 50: 650-653 (1997).

• Ishihara M, Ohno S, Mizuki N, Yamagata N, Ishida T, Naruse T, Ando A, Inoko H. LMP7 polymorphism in Japanese patients with sarcoidosis and Behcet's disease. Hum. Immunol. 51: 103-105 (1996).

• Ishihara M, Ohno S, Mizuki N, Yamagata N, Ishida T, Naruse T, Kuwata S, Inoko H. Genetic polymorphisms of the major histocompatibility complex-encoded antigen-processing genes TAP and LMP in sarcoidosis. Hum. Immunol. 45: 105-110 (1996).

• Isobe Z, Suga T, Hamaguchi S, Yamaguchi S, Hara K, Aoki F, Aoki N, Aoyagi K, Ueno M, Maeno T, Kurabayashi M. A case of HLA-DR8 positive sarcoidosis following polymyositis and Sjogren's syndrome. Nihon Kokyuki Gakkai Zasshi 46: 96-100 (2008).

• Ito M, Yasuo M, Yamamoto H, Tsushima K, Tanabe T, Yokoyama T, Hamano H, Kawa S, Uehara T, Honda T, Kawakami S, Kubo K. Central airway stenosis in a patient with autoimmune pancreatitis. Eur. Respir. J. 33: 680-683 (2009).

• Jakob E, Reuland MS, Mackensen F, Harsch N, Fleckenstein M, Lorenz HM, Max R, Becker MD. Uveitis subtypes in a German Interdisciplinary Uveitis Center - analysis of 1916 patients. J. Rheumatol. 36: 127-136 (2009).

• James DG. Sarcoidosis 2001. Postgrad. Med. J. 77: 177-180 (2001). *

• James DG. A comparison of Blau's syndrome and sarcoidosis. Sarcoidosis 11: 100-101 (1994).

• James DG, Sharma OP. Overlap syndromes with sarcoidosis. Sarcoidosis 2: 116-121 (1985).

• James DG, Vella M. Hepatic granulomas. Sarcoidosis 3: 30-33 (1986).

• Janossy G, Montano L, Selby WS, Duke O, Panayi G, Lampert I, Thomas JA, Granger S, Bofill M, Tidman N, Thomas HC, Goldstein G. T cell subset abnormalities in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host disease. J. Clin. Immunol. 2: 42S-56S (1982).

• Janssen R, Kruit A, Grutters JC, van den Bosch JM. Interleukin-18-607 promoter polymorphism in sarcoidosis: ignoring "negative" results. Am. J. Respir. Crit. Care Med. 173: 814 (2006). *

• Javaud N, Belenfant X, Stirnemann J, Laederich J, Ziol M, Callard P, Ronco P, Rondeau E, Fain O. Renal granulomatoses: a retrospective study of 40 cases and review of the literature. Medicine (Baltimore) 86: 170-180 (2007).

• Javidan-Nejad C, Bhalla S. Bronchiectasis. Radiol. Clin. North Am. 47: 289-306 (2009).

• Jiang R, Dong J, Dai Y. Genome-wide association study of rheumatoid arthritis by a score test based on wavelet transformation. BMC Proc. 3 Suppl. 7: S8 (2009). *

• Johansen J. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan. Med. Bull. 5: 172-209 (2006).

• Johnson CM, Traherne JA, Jamieson SE, Tremelling M, Bingham S, Parkes M, Blackwell JM, Trowsdale J. Analysis of the BTNL2 truncating splice site mutation in tuberculosis, leprosy and Crohn's disease. Tissue Antigens 69: 236-241 (2007). *

• Jonth AC, Silveira L, Fingerlin TE, Sato H, Luby JC, Welsh KI, Rose CS, Newman LS, du Bois RM, Maier LA; ACCESS Group. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis. J. Immunol. 179: 4255-4262 (2007). *

• Judson MA, Silvestri J, Hartung C, Byars T, Cox CE. The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 23: 51-57 (2006).

• Kaarteenaho-Wiik R, Soini Y. Claudin -1, -2, -3, -4, -5, and -7 in usual interstitial pneumonia and sarcoidosis. J. Histochem. Cytochem. 57: 187-195 (2009). *

• Kaassis M, Rabot AF, Person C, Boyer J. Primary sclerosing cholangitis and sarcoidosis. Ann. Med. Interne. (Paris) 148: 456-458 (1997).

• Kalkan IH, Kalkan IK, Tuzun D, Suher M. Sarcoidosis with granulomatous hepatitis and autoimmune endocrine involvement. Ann. Acad. Med. Singapore 37: 977-972 (2008). *

• Kambe N, Nishikomori R, Kanazawa N. The cytosolic pattern-recognition receptor Nod2 and inflammatory granulomatous disorders. J. Dermatol. Sci. 39: 71-80 (2005).

• Kanazawa N. Clinical features of Blau syndrome and early-onset sarcoidosis and associating CARD15/NOD2 gene mutations. Nihon Rinsho Meneki Gakkai Kaishi 30: 123-132 (2007). *

• Kanazawa N, Furukawa F. Autoinflammatory syndromes with a dermatological perspective. J. Dermatol. 34: 601-618 (2007).

• Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, Fuji A, Yuasa T, Manki A, Sakurai Y, Nakajima M, Kobayashi H, Fujiwara I, Tsutsumi H, Utani A, Nishigori C, Heike T, Nakahata T, Miyachi Y. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105: 1195-1197 (2005). *

• Kanski JJ. Care of children with anterior uveitis. Trans. Ophthalmol. Soc. U.K. 101: 387-390 (1981).

• Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepatic sarcoidosis. Ann. Hepatol. 5: 251-256 (2006). *

• Karakelides H, Geller JL, Schroeter AL, Chen H, Behn PS, Adams JS, Hewison M, Wermers RA. Vitamin D-mediated hypercalcemia in slack skin disease: evidence for involvement of extrarenal 25-hydroxyvitamin d 1alpha-hydroxylase. J. Bone Miner. Res. 21: 1496-1499 (2006). *

• Karatolios K, Pankuweit S, Maisch B. Diagnosis and treatment of myocarditis: the role of endomyocardial biopsy. Curr. Treat. Options Cardiovasc. Med. 9: 473-481 (2007).

• Keeffe EB. Sarcoidosis and primary biliary cirrhosis. Literature review and illustrative case. Am. J. Med. 83: 977-980 (1987).

• Keller K, Hofmann WJ, Kayser K, Limberg B, Lippert J, Werner A, Andrassy K, Hahn P, Stremmel W, Galle PR. Coincidence of primary sclerosing cholangitis and sarcoidosis - case report and review of the literature. Z. Gastroenterol. 35: 33-39 (1997).

• Kestelyn PG. An eye on inflammatory eye disease. Acta Clin. Belg. 60: 270-275 (2005).

• Keystone EC. The utility of tumour necrosis factor blockade in orphan diseases. Ann. Rheum. Dis. 63 Suppl. 2: ii79-ii83 (2004). *

• Kiltz U, Brandt J, Zochling J, Braun J. Rheumatic manifestations of lymphoproliferative disorders. Clin. Exp. Rheumatol. 25: 35-39 (2007).

• Kim WR, Ludwig J, Lindor KD. Variant forms of cholestatic diseases involving small bile ducts in adults. Am. J. Gastroenterol. 95: 1130-1138 (2000). *

• Kimani AP, Aguayo SM. Sarcoidosis: an overview for the primary care physician. Compr. Ther. 24: 20-25 (1998).

• Kirman I, Vainer B, Nielsen OH. Interleukin-15 and its role in chronic inflammatory diseases. Inflamm. Res. 47: 285-289 (1998). *

• Kishor S, Turner ML, Borg BB, Kleiner DE, Cowen EW. Cutaneous sarcoidosis and primary biliary cirrhosis: a chance association or related diseases? J. Am. Acad. Dermatol. 58: 326-335 (2008).

• Kitaichi N, Kitamura M, Namba K, Ishida S, Ohno S. Elevation of surfactant protein D, a pulmonary disease biomarker, in the sera of uveitis patients with sarcoidosis. Jpn. J. Ophthalmol. 54: 81-84 (2010). *

• Kitamura M, Ishizaki T. Sarcoidosis of the liver and spleen in Japan. Nippon Rinsho 52: 1595-1598 (1994).

• Kittisupamongkol W. Angiotensin-converting enzyme levels in chronic sarcoidosis. Am. J. Gastroenterol. 104: 1321 (2009). *

• Knoell KA, Hendrix JD Jr, Stoler MH, Patterson JW, Montes CM. Absence of human herpesvirus 8 in sarcoidosis and Crohn disease granulomas. Arch. Dermatol. 141: 909-910 (2005). *

• Knysz B, Rogowska-Szadkowska D, Gasiorowski J, Gladysz A. Immune reconstitution syndromes secondary to effective antiretroviral therapy. Postepy. Hig. Med. Dosw. (Online) 59: 180-187 (2005).

• Koufane J, Afifi Y, Khoudri I, Rmili M, Senouci K, Kettani F, Benouda A, Hassam B, Ismaili N. Baker Rosenbach erysipeloid appearing as a granulomatous cheilitis. Ann. Dermatol. Venereol. 137: 124-127 (2010).

• Kramers C, Adema GJ, Korte M, Deinum J. Familial hyperactivity of angiotensin-converting enzyme (ACE). Ned. Tijdschr. Geneeskd. 147: 507-510 (2003).

• Krawczyk A. Genetic background of sarcoidosis. Pol. Merkur. Lekarski. 22: 243-248 (2007).

• Kreider ME, Christie JD, Thompson B, Newman L, Rose C, Barnard J, Bresnitz E, Judson MA, Lackland DT, Rossman MD. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 128: 207-215 (2005). *

• Krenn V, Jakobs M, Kriegsmann J, Krukemeyer MG, Rieger A. Is bioptic assurance reasonable in patients with Sjogren's syndrome? From focus score to diagnosing vasculitides. Z. Rheumatol. 69: 11-18 (2010).

• Kroner A, Grimm A, Johannssen K, Maurer M, Wiendl H. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis. Hum. Immunol. 68: 422-435 (2007).

• Kruit A, Grutters JC, Gerritsen WB, Kos S, Wodzig WK, van den Bosch JM, Ruven HJ. ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respir. Med. 101: 510-515 (2007).

• Kubistova Z, Mrazek F, Petrek M. Polymorphisms of the immune response genes: selected biological, methodical and medical aspects. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub. 153: 93-102 (2009).

• Kulakova N, Urban B, McMichael AJ, Ho LP. Functional analysis of dendritic cell-T cell interaction in sarcoidosis. Clin. Exp. Immunol. 159: 82-86 (2010). *

• Landgren O, Engels EA, Pfeiffer RM, Gridley G, Mellemkjaer L, Olsen JH, Kerstann KF, Wheeler W, Hemminki K, Linet MS, Goldin LR. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J. Natl. Cancer Inst. 98: 1321-1330 (2006). *

• Lange A. Genetic factors predicting IFN-gamma generation potential in patients with sarcoidosis and after haematopoietic stem cell transplantation. Int. J. Immunogenet. 35: 385-388 (2008). *

• Larousserie F, Pflanz S, Coulomb-L'Hermine A, Brousse N, Kastelein R, Devergne O. Expression of IL-27 in human Th1-associated granulomatous diseases. J. Pathol. 202: 164-171 (2004). *

• Lavie F, Miceli-Richard C, Quillard J, Roux S, Leclerc P, Mariette X. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. J. Pathol. 202: 496-502 (2004). *

• Layden TJ, Kulik L. Hepatic manifestations of pulmonary diseases. Clin. Liver Dis. 6: 969-979, ix (2002).

• Lazebnik LB, Parfenov AI. Crohn’s disease of small intestine: versions of clinical picture and problems of differential diagnosis. Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, pp. 43-44 (2006). *

• Lazzarini LC, de Fatima do Amparo Teixeira M, Souza Rodrigues R, Marcos Nunes Valiante P. Necrotizing sarcoid granulomatosis in a family of patients with sarcoidosis reinforces the association between both entities. Respiration 76: 356-360 (2007). *

• Leao JC, Hodgson T, Scully C, Porter S. Review article: orofacial granulomatosis. Aliment. Pharmacol. Ther. 20: 1019-1027 (2004). *

• Leslie KO. Pathology of interstitial lung disease. Clin. Chest Med. 25: 657-703 (2004).

• Li Y, Ayata G, Baker SP, Banner BF. Cholangitis: a histologic classification based on patterns of injury in liver biopsies. Pathol. Res. Pract. 201: 565-572 (2005).

• Li Y, Wollnik B, Pabst S, Lennarz M, Rohmann E, Gillissen A, Vetter H, Grohe C. BTNL2 gene variant and sarcoidosis. Thorax 61: 273-274 (2006). *

• Lian Y, Yue J, Han M, Liu J, Liu L. Analysis of the association between BTNL2 polymorphism and tuberculosis in Chinese Han population. Infect. Genet. Evol. Feb 19 [Epub ahead of print] (2010).

• Lidar M, Langevitz P, Livneh A, Weiss P, Yosepovich A. Sclerosing cholangitis associated with systemic sarcoidosis. J. Clin. Gastroenterol. 36: 84-85 (2003).

• Lis-Swiety A, Brzezinska-Wcislo L, Pierzchala E, Wcislo-Dziadecka D. Systemic sclerosis-polymyositis overlap syndrome accompanied by autoimmune hepatitis and sarcoidosis of mediastinal lymphnodes. J. Eur. Acad. Dermatol. Venereol. 20: 107-108 (2006).

• Lopez Rodriguez M, Garcia Arias M, Gomez Cerezo J. Biological therapy with anti-TNF antibodies. Extending the spectrum of its indications? Rev. Clin. Esp. 207: 448-450 (2007).

• Lopez-Campos JL, Rodriguez-Rodriguez D, Rodriguez-Becerra E, Michavila IA, Guerra JF, Hernandez FJ, Casanova A, de Cordoba Gamero JF, Ortiz AR, Arellano-Orden E, Montes-Worboys A. Association of the 3050G>C polymorphism in the cyclooxygenase 2 gene with systemic sarcoidosis. Arch. Med. Res. 39: 525-530 (2008).

• Ludvigsson JF, Wahlstrom J, Grunewald J, Ekbom A, Montgomery SM. Coeliac disease and risk of sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 24: 121-126 (2007).

• Ludwig J, Colina F, Poterucha JJ. Granulomas in primary sclerosing cholangitis. Liver 15: 307-312 (1995).

• Ma Y, Gal A, Koss MN. The pathology of pulmonary sarcoidosis: update. Semin. Diagn. Pathol. 24: 150-161 (2007).

• Maambo E, Brett AS, Vasudeva R, Burns RG. Hepatobiliary sarcoidosis presenting as sclerosing cholangitis: long-term follow-up. Dig. Dis. Sci. 52: 3363-3365 (2007). *

• Maca SM, Scharitzer M, Barisani-Asenbauer T. Uveitis and neurologic diseases: an often overlooked relationship. Wien. Klin. Wochenschr. 118: 273-279 (2006). *

• Mackay IR. Foreword. Contemporary liver immunology and immunopathology: obstacles and opportunities. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 1-14 (2007). *

• Malhotra A, Naniwadekar A, Sood G. Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis. J. Gastroenterol. Hepatol. 23: 1942 (2008). *

• Maliarik MJ, Chen KM, Sheffer RG, Rybicki BA, Major ML, Popovich J Jr, Iannuzzi MC. The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis. Am. J. Respir. Cell Mol. Biol. 22: 672-675 (2000). *

• Malphettes M, Oksenhendler E, Galicier L, Fieschi C. Granulomatous disease in common variable immunodeficiency. Rev. Med. Interne. 29: 28-32 (2008).

• Mangas C, Fernandez-Figueras MT, Fite E, Fernandez-Chico N, Sabat M, Ferrandiz C. Clinical spectrum and histological analysis of 32 cases of specific cutaneous sarcoidosis. J. Cutan. Pathol. 33: 772-777 (2006). *

• Manouvrier-Hanu S, Puech B, Piette F, Boute-Benejean O, Desbonnet A, Duquesnoy B, Farriaux JP. Blau syndrome of granulomatous arthritis, iritis, and skin rash: a new family and review of the literature. Am. J. Med. Genet. 76: 217-221 (1998).

• Mansour MJ, Al-Hashimi I, Wright JM. Coexistence of Sjogren's syndrome and sarcoidosis: a report of five cases. J. Oral Pathol. Med. 36: 337-341 (2007). *

• Margolis R, Lowder CY. Sarcoidosis. Curr. Opin. Ophthalmol. 18: 470-475 (2007).

• Marshall TG, Marshall FE. Sarcoidosis succumbs to antibiotics-implications for autoimmune disease. Autoimmun. Rev. 3: 295-300 (2004).

• Marten K, Rummeny EJ, Engelke C. The CT halo: a new sign in active pulmonary sarcoidosis. Br. J. Radiol. 77: 1042-1045 (2004). *

• Martin TM, Doyle TM, Smith JR, Dinulescu D, Rust K, Rosenbaum JT. Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am. J. Ophthalmol. 136: 933-935 (2003). *

• Martin WJ 2nd, Iannuzzi MC, Gail DB, Peavy HH. Future directions in sarcoidosis research: summary of an NHLBI working group. Am. J. Respir. Crit. Care Med. 170: 567-571 (2004). *

• Martin-Blondel G, Camara B, Selves J, Robic MA, Thebault S, Bonnet D, Alric L. Etiology and outcome of liver granulomatosis: a retrospective study of 21 cases. Rev. Med. Interne. Dec 3 [Epub ahead of print] (2009).

• Masaki Y, Umehara H. IgG4-related disease-the diagnostic confusion and how to avoid it. Nihon Rinsho Meneki Gakkai Kaishi 32: 478-483 (2009).

• Masel G, Halbert A. Blau syndrome presenting with ichthyosis. Australas. J. Dermatol. 46: 29-32 (2005).

• Massara A, Cavazzini L, La Corte R, Trotta F. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review. Semin. Arthritis Rheum. Jan 14 [Epub ahead of print] (2009). *

• Maver A, Medica I, Salobir B, Sabovic M, Tercelj M, Peterlin B. Polymorphisms in genes coding for mediators in the interleukin cascade and their effect on susceptibility to sarcoidosis in the Slovenian population. Int. J. Mol. Med. 20: 385-390 (2007). *

• Maver A, Medica I, Salobir B, Tercelj M, Peterlin B. Genetic variation in osteopontin gene is associated with susceptibility to sarcoidosis in Slovenian population. Dis. Markers 27: 295-302 (2009).

• Maver A, Medica I, Salobir B, Tercelj-Zorman M, Sabovic M, Petrovic D, Peterlin B. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 25: 29-35 (2008).

• Mayo I, Arribas J, Villoslada P, Alvarez DoForno R, Rodriguez-Vilarino S, Montalban X, De Sagarra MR, Castano JG. The proteasome is a major autoantigen in multiple sclerosis. Brain 125: 2658-2667 (2002). *

• McCaskill JG, Chason KD, Hua X, Neuringer IP, Ghio AJ, Funkhouser WK, Tilley SL. Pulmonary immune responses to Propionibacterium acnes in C57BL/6 and BALB/c mice. Am. J. Respir. Cell. Mol. Biol. 35: 347-356 (2006). *

• McDougal KE, Fallin MD, Moller DR, Song Z, Cutler DJ, Steiner LL, Cutting GR. Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis. J. Invest. Dermatol. 129: 1921-1926 (2009). *

• Medica I, Kastrin A, Maver A, Peterlin B. Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis. J. Hum. Genet. 52: 836-847 (2007). *

• Mellemkjaer L, Pfeiffer RM, Engels EA, Gridley G, Wheeler W, Hemminki K, Olsen JH, Dreyer L, Linet MS, Goldin LR, Landgren O. Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum. 58: 657-666 (2008). *

• Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J. Nucl. Med. 48: 35-45 (2007). *

• Meloni F, Solari N, Cavagna L, Morosini M, Montecucco CM, Fietta AM. Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. Clin. Exp. Rheumatol. 27: 765-772 (2009).

• Mendelson DS, Simpson W, Yeh HC. Right upper quadrant pain and fever in a patient with pulmonary sarcoidosis. Semin. Liver Dis. 21: 293-296 (2001).

• Menezo V, Lobo A, Yeo TK, du Bois RM, Lightman S. Ocular features in neurosarcoidosis. Ocul. Immunol. Inflamm. 17: 170-178 (2009). *

• Menias CO, Surabhi VR, Prasad SR, Wang HL, Narra VR, Chintapalli KN. Mimics of cholangiocarcinoma: spectrum of disease. Radiographics 28: 1115-1129 (2008). *

• Mert A, Kumbasar H, Ozaras R, Erten S, Tasli L, Tabak F, Ozturk R. Erythema nodosum: an evaluation of 100 cases. Clin. Exp. Rheumatol. 25: 563-570 (2007).

• Metyas SK, Tadros RM, Arkfeld DG. Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis. Rheumatol. Int. 29: 437-439 (2009). *

• Meyer T, Lauschke J, Ruppert V, Richter A, Pankuweit S, Maisch B. Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology 109: 117-121 (2007).

• Meyer T, Lauschke J, Ruppert V, Richter A, Pankuweit S, Maisch B. BTNL2 polymorphism and cardiac sarcoidosis. Cardiology 112: 78-79 (2008).

• Michels H, Greiner K, Heinz C, Horneff G, Ganser G. Other rheumatic diseases with uveitis besides juvenile idiopathic arthritis. Klin. Monatsbl. Augenheilkd. 224: 473-476 (2007).

• Mihailovic-Vucinic V, Videnovic-Ivanov J, Gostiljac D, Filipovic S, Maric J. Chronic sarcoidosis. Med. Pregl. 58 Suppl. 1: 39-43 (2005).

• Milman N, Andersen CB, Hansen A, van Overeem Hansen T, Nielsen FC, Fledelius H, Ahrens P, Nielsen OH. Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. APMIS 114: 912-919 (2006). *

• Milman N, Byg KE. Blau syndrome: a chronic granulomatous, genetic disease. Ugeskr. Laeger. 168: 3612-3614 (2006).

• Milman N, Nielsen OH, Hviid TV, Fenger K. CARD15 single nucleotide polymorphisms 8, 12 and 13 are not increased in ethnic Danes with sarcoidosis. Respiration 74: 76-79 (2007).

• Mistry N, Shapero J, Crawford RI. A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. Can. J. Gastroenterol. 23: 677-683 (2009).

• Mitchell DN, Rees RJ, Goswami KK. Transmissible agents from human sarcoid and Crohn's disease tissues. Lancet 2: 761-765 (1976).

• Miura K, Takahashi K, Fukuchi Y. Role of biochemical markers in sarcoidosis. Nippon Rinsho 60: 1741-1746 (2002).

• Mochida A, Kinouchi Y, Negoro K, Takahashi S, Takagi S, Nomura E, Kakuta Y, Tosa M, Shimosegawa T. Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1*1502. Tissue Antigens 70: 128-135 (2007). *

• Modrzewska K, Wiatr E, Langfort R, Oniszh K, Roszkowski-Sliz K. Common variable immunodeficiency in a patient with suspected sarcoidosis. Pneumonol. Alergol. Pol. 77: 91-96 (2009).

• Moller M, Kwiatkowski R, Nebel A, van Helden PD, Hoal EG, Schreiber S. Allelic variation in BTNL2 and susceptibility to tuberculosis in a South African population. Microbes Infect. 9: 522-528 (2007). *

• Mongil Ruiz I, Canduela Martinez V. Periodic fever. An. Esp. Pediatr. 57: 334-344 (2002).

• Moraillon I, Hayem F, Bourrillon A, Morel P, Rybojad M. Blau syndrome or familial form of sarcoidosis with onset during infancy. Ann. Dermatol. Venereol. 123: 29-30 (1996).

• Morais A, Alves H, Lima B, Delgado L, Goncalves R, Tafulo S. HLA class I and II and TNF-alpha gene polymorphisms in sarcoidosis patients. Rev. Port. Pneumol. 14: 727-746 (2008).

• Moravan M, Segal BM. Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology 72: 337-340 (2009).

• Mortele KJ, Ros PR. Imaging of diffuse liver disease. Semin. Liver Dis. 21: 195-212 (2001).

• Mosimann F, Burri B, Mosimann R. 9 cases of portal hypertension of rare etiology. Helv. Chir. Acta 46: 811-814 (1980).

• Mrazek F, Holla LI, Hutyrova B, Znojil V, Vasku A, Kolek V, Welsh KI, Vacha J, du Bois RM, Petrek M. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 65: 163-171 (2005). *

• Mueller S, Boehme MW, Hofmann WJ, Stremmel W. Extrapulmonary sarcoidosis primarily diagnosed in the liver. Scand. J. Gastroenterol. 35: 1003-1008 (2000). *

• Muhling O, El-Nounou M, Schafer C, Muhlbayer D, Tympner C, Behr J. A 52-year-old patient with positive troponin, iron deficiency anemia and known sarcoidosis. Internist (Berl.) 47: 1279-1283 (2006).

• Mullauer L, Emhofer J, Wohlfart S, Pichlhofer B, Stary S, Ebetsberger G, Mannhalter C, Chott A. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis. Am. J. Surg. Pathol. 32: 329-334 (2008).

• Muller BR. Analysis of serum angiotensin-converting enzyme. Ann. Clin. Biochem. 39: 436-443 (2002).

• Muro M, Marin L, Torio A, Pagan JA, Alvarez-Lopez MR. CCL5/RANTES chemokine gene promoter polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population. Int. J. Immunogenet. 35: 19-23 (2008). *

• Murphy JR, Sjogren MH, Kikendall JW, Peura DA, Goodman Z. Small bile duct abnormalities in sarcoidosis. J. Clin. Gastroenterol. 12: 555-561 (1990).

• Nagai S, Handa T, Ito Y, Ohta K, Tamaya M, Izumi T. Outcome of sarcoidosis. Clin. Chest Med. 29: 565-574 (2008).

• Najjar S, Bernbaum M, Lai G, Devinsky O. Immunology and epilepsy. Rev. Neurol. Dis. 5: 109-116 (2008).

• Nakanuma Y, Kouda W, Harada K, Hiramatsu K. Hepatic sarcoidosis with vanishing bile duct syndrome, cirrhosis, and portal phlebosclerosis. Report of an autopsy case. J. Clin. Gastroenterol. 32: 181-184 (2001).

• Nakanuma Y, Ohta G, Yamazaki Y, Doishita K. Intrahepatic bile duct destruction in a patient with sarcoidosis and chronic intrahepatic cholestasis. Acta Pathol. Jpn. 29: 211-219 (1979).

• Nakata Y, Kataoka M, Kimura I. Sarcoidosis and Propionibacterium acnes. Nippon Rinsho 52: 1492-1497 (1994).

• Nakayama S, Mukae H, Morisaki T, Sakamoto N, Ohba K, Abe K, Takeshima F, Mizuta Y, Ida H, Ozono Y, Kohno S. Sarcoidosis accompanied by systemic lupus erythematosus and autoimmune hepatitis. Intern. Med. 46: 1657-1661 (2007). *

• Naser S, Shafran I, El-Zaatari F. Mycobacterium avium subsp. paratuberculosis in Crohn's disease is serologically positive. Clin. Diagn. Lab. Immunol. 6: 282 (1999). *

• Navratilova Z, Mrazek F, Kriegova E, Hutyrova B, Kolek V, du Bois RM, Petrek M. The MCP-1-2518 (A to G) single nucleotide polymorphism in Czech patients with pulmonary sarcoidosis: association with Lofgren's syndrome. Sarcoidosis Vasc. Diffuse Lung Dis. 24: 33-38 (2007).

• Neuberger J, Jothimani D. Long-term immunosuppression for prevention of nonviral disease recurrence. Transplant. Proc. 37: 1671-1674 (2005). *

• Newman LS, Rose CS, Maier LA. Sarcoidosis. N. Engl. J. Med. 336: 1224-1234 (1997). *

• Nguyen T, Liu XK, Zhang Y, Dong C. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J. Immunol. 176: 7354-7360 (2006). *

• Nigro A, Iannone F, Grattagliano V, Sanguedolce F, Lapadula G. Sarcoidosis presenting with Raynaud's syndrome: a case report. Reumatismo 56: 278-281 (2004).

• Nikolopoulou M, Katsenos S, Psathakis K, Rallis E, Sampaziotis D, Panagou P, Tsintiris K, Bouros D. Pulmonary sarcoidosis associated with psoriasis vulgaris: coincidental occurrence or causal association? Case report. BMC Pulm. Med. 6: 26 (2006). *

• Nilubol N, Taub PJ, Venturero M, Lichtiger S, Bauer JJ. Ulcerative colitis and sarcoidosis. Mt. Sinai J. Med. 68: 400-402 (2001). *

• Ninomiya S, Niimi T, Shimizu S, Sato S, Achiwa H, Ito H, Akita K, Maeda H, Ueda R. Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients. Sarcoidosis Vasc. Diffuse Lung Dis. 21: 19-24 (2004).

• Noor A, Knox KS. Immunopathogenesis of sarcoidosis. Clin. Dermatol. 25: 250-258 (2007).

• Nunes H, Bouvry D, Soler P, Valeyre D. Sarcoidosis. Orphanet J. Rare Dis. 2: 46 (2007). *

• Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy 60: 565-582 (2005). *

• O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J. Cell. Physiol. 201: 167-180 (2004). *

• Ogawa Y, Tominaga T, Ikeda H. Neurosarcoidosis manifesting as tremor of the extremities and severe hypopituitarism: case report. Neurol. Med. Chir. (Tokyo) 48: 314-317 (2008).

• Ohshimo S, Bonella F, Grammann N, Starke K, Cui A, Bauer PC, Teschler H, Kohno N, Guzman J, Costabel U. Serum KL-6 as a novel disease marker in adolescent and adult cystic fibrosis. Sarcoidosis Vasc. Diffuse Lung Dis. 26: 47-53 (2009).

• Ohta A, Nagai M, Nishina M, Shibazaki S, Ishijima H, Izumida M. Age at the onset of intractable disease: based on a clinical database for patients receiving financial aid for treatment. Nippon Koshu Eisei Zasshi 54: 3-14 (2007).

• Okafuji I, Nishikomori R, Kanazawa N, Kambe N, Fujisawa A, Yamazaki S, Saito M, Yoshioka T, Kawai T, Sakai H, Tanizaki H, Heike T, Miyachi Y, Nakahata T. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. 60: 242-250 (2009). *

• Okunuki Y, Usui Y, Kezuka T, Hattori T, Masuko K, Nakamura H, Yudoh K, Goto H, Usui M, Nishioka K, Kato T, Takeuchi M. Proteomic surveillance of retinal autoantigens in endogenous uveitis: implication of esterase D and brain-type creatine kinase as novel autoantigens. Mol. Vis. 14: 1094-1104 (2008). *

• Onal IK, Ersoy O, Aydinli M, Yonem O, Harmanci O, Sokmensuer C, Bayraktar Y. Hepatic granuloma in Turkish adults: a report of 13 cases. Eur. J. Intern. Med. 19: 527-530 (2008).

• Orchard TR, Chua CN, Ahmad T, Cheng H, Welsh KI, Jewell DP. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology 123: 714-718 (2002). *

• Oremovic L, Lugovic L, Vucic M, Buljan M, Ozanic-Bulic S. Cicatricial alopecia as a manifestation of different dermatoses. Acta Dermatovenerol. Croat. 14: 246-252 (2006).

• Ormann W. Association of primary biliary liver cirrhosis with sarcoidosis - separate diseases or a new nosological entity? Dtsch. Med. Wochenschr. 112: 1082-1085 (1987).

• Oruc N, Lamb J, Kutlu OC, Barmada MM, Money ME, Slivka A, Whitcomb DC. The functional angiotensin converting enzyme gene I/D polymorphism does not alter susceptibility to chronic pancreatitis. JOP 5: 457-463 (2004). *

• Oruc N, Lamb J, Whitcomb DJ, Sass DA. The ACE gene I/D polymorphism does not affect the susceptibility to or prognosis of PBC. Turk. J. Gastroenterol. 19: 250-253 (2008). *

• Ossi E, Rossanese A, Casagrande F, Rotilio A, Mingrino S, Poci C. Predictive value of ANCA in atypical primary brain localization of Wegener's granulomatosis. Sarcoidosis Vasc. Diffuse Lung Dis. 19: 78-80 (2002).

• Oswald-Richter K, Sato H, Hajizadeh R, Shepherd BE, Sidney J, Sette A, Newman LS, Drake WP. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101. J. Clin. Immunol. Jun 18 [Epub ahead of print] (2009). *

• Pabst S, Baumgarten G, Stremmel A, Lennarz M, Knufermann P, Gillissen A, Vetter H, Grohe C. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin. Exp. Immunol. 143: 420-426 (2006). *

• Page M. Nursing care and management of patients with sarcoidosis. Br. J. Nurs. 17: 252-257 (2008).

• Papachristou GI, Demetris AJ, Craig F, Lee KKW, Rabinovitz M. Cholestatic jaundice and bone lesions in an elderly woman. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 53-57 (2004). *

• Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT. Ear-nose-throat manifestations of autoimmune rheumatic diseases. Clin. Exp. Rheumatol. 22: 485-494 (2004).

• Papadopoulos KI, Hornblad Y, Liljebladh H, Hallengren B. High frequency of endocrine autoimmunity in patients with sarcoidosis. Eur. J. Endocrinol. 134: 331-336 (1996).

• Pasquet F, Cottin V, Sivova N, Le Scanff J, Broussolle C, Seve P. Coexisting relapsing polychondritis and sarcoidosis: an unusual association. Rheumatol. Int. Aug 28 [Epub ahead of print] (2009). *

• Pereira-Lima J, Schaffner F. Chronic cholestasis in hepatic sarcoidosis with clinical features resembling primary biliary cirrhosis. Report of two cases. Am. J. Med. 83: 144-148 (1987).

• Perri AJ 3rd, Hsu S. A review of thalidomide's history and current dermatological applications. Dermatol. Online J. 9: 5 (2003). *

• Perry AL, Lambert PA. Propionibacterium acnes. Lett. Appl. Microbiol. 42: 185-188 (2006). *

• Pesci A, Pavone L, Buzio C, Manganelli P. Respiratory system involvement in ANCA-associated systemic vasculitides. Sarcoidosis Vasc. Diffuse Lung Dis. 22 Suppl. 1: S40-S48 (2005).

• Petrek M, Gibejova A, Drabek J, Mrazek F, Kolek V, Weigl E, du Bois RM. CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis. Immunol. Lett. 80: 189-193 (2002).

• Petropoulos IK, Vaudaux JD, Guex-Crosier Y. Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of Jules Gonin Eye Hospital. Klin. Monatsbl. Augenheilkd. 225: 457-461 (2008).

• Petzmann S, Maercker C, Markert E, Kern I, Osolnik K, Pohl W, Popper HH. Enhanced proliferation and decreased apoptosis in lung lavage cells of sarcoidosis patients. Sarcoidosis Vasc. Diffuse Lung Dis. 23: 190-200 (2006).

• Peyre CG, Wakim M, Mateo R, Genyk Y, Singh G, Selby RR, Jabbour N. Unusual cases of jaundice secondary to non-neoplastic bile duct obstruction. Am. Surg. 70: 620-624 (2004).

• Phillips J, Staszewski H, Garrison M. Successful treatment of secondary hemophagocytic lymphohistiocytosis in a patient with disseminated histoplasmosis. Hematology 13: 282-285 (2008).

• Pinto P, Dougados M. Leflunomide in clinical practice. Acta Reumatol. Port. 31: 215-224 (2006).

• Plant BJ, Ghani S, O'Mahony MJ, Morgan L, O'Connor CM, Morgan K, Baugh JA, Donnelly SC. Sarcoidosis and a MIF gene polymorphism: a case-control study in an Irish population. Eur. Respir. J. 29: 325-329 (2007). *

• Pleyer U, Dutescu M. Sympathetic ophthalmia. Ophthalmologe 106: 167-176 (2009).

• Porter WM, Hardman CM, Leonard JN, Fry L. Sarcoidosis in a patient with linear IgA disease. Clin. Exp. Dermatol. 24: 67-70 (1999). *

• Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum and sarcoidosis. Arch. Dermatol. 120: 959-960 (1984).

• Pras E, Neumann R, Zandman-Goddard G, Levy Y, Assia EI, Shoenfeld Y, Langevitz P. Intraocular inflammation in autoimmune diseases. Semin. Arthritis Rheum. 34: 602-609 (2004). *

• Prasse A, Stahl M, Schulz G, Kayser G, Wang L, Ask K, Yalcintepe J, Kirschbaum A, Bargagli E, Zissel G, Kolb M, Muller-Quernheim J, Weiss JM, Renkl AC. Essential role of osteopontin in smoking-related interstitial lung diseases. Am. J. Pathol. 174: 1683-1691 (2009). *

• Priori R, Bombardieri M, Spinelli FR, Merlin F, Miceli-Richard C, La Cava M, Scavalli AS, Guerrisi R, Hugot JP, Valesini G. Sporadic Blau syndrome with a double CARD15 mutation. Report of a case with lifelong follow-up. Sarcoidosis Vasc. Diffuse Lung Dis. 21: 228-231 (2004).

• Pritchard C, Nadarajah K. Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients. Ann. Rheum. Dis. 63: 318-320 (2004). *

• Qureshi WA. Intrahepatic cholestatic syndromes: pathogenesis, clinical features and management. Dig. Dis. 17: 49-59 (1999).

• Raedler A, Bredow G, Kirch W, Thiele HG, Greten H. In vivo activated peripheral T cells in autoimmune disease. J. Clin. Lab. Immunol. 19: 181-186 (1986).

• Rajoriya N, Wotton CJ, Yeates DG, Travis SP, Goldacre MJ. Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database. Postgrad. Med. J. 85: 233-237 (2009).

• Ramos-Casals M, Brito-Zeron P, Munoz S, Soto MJ; the BIOGEAS STUDY Group. A systematic review of the off-label use of biological therapies in systemic autoimmune diseases. Medicine (Baltimore) 87: 345-364 (2008).

• Ramos-Casals M, Brito-Zeron P, Soto MJ, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by TNF-targeted therapies. Best Pract. Res. Clin. Rheumatol. 22: 847-861 (2008).

• Ramos-Casals M, Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr. Opin. Rheumatol. 17: 447-455 (2005).

• Ramos-Casals M, Munoz S, Medina F, Jara LJ, Rosas J, Calvo-Alen J, Brito-Zeron P, Forns X, Sanchez-Tapias JM. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (the HISPAMEC registry). J. Rheumatol. 36: 1442-1448 (2009).

• Ramos-Casals M, Perez-Alvarez R, Diaz-Lagares C, Cuadrado MJ, Khamashta MA; the BIOGEAS Study Group. Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun. Rev. Oct 22 [Epub ahead of print] (2009).

• Raphael SA, Blau EB, Zhang WH, Hsu SH. Analysis of a large kindred with Blau syndrome for HLA, autoimmunity, and sarcoidosis. Am. J. Dis. Child. 147: 842-848 (1993).

• Reddy HS, Khurana RN, Rao NA, Chopra V. Granuloma annulare anterior uveitis. Ocul. Immunol. Inflamm. 16: 55-57 (2008).

• Reddy RC. Immunomodulatory role of PPAR-gamma in alveolar macrophages. J. Investig. Med. 56: 522-527 (2008).

• Reggiani A, Dizioli P, Quattrocchi D, Quinzani M, Marelli A, Bodini P. Intrahepatic cholestasis: clinical and nosological classification. Critical survey of personal experience. Minerva Gastroenterol. Dietol. 43: 71-81 (1997).

• Reggoug S, Benelbarhdadi I, Essamri W, Ajana FZ, Afifi R, Benazzouz M, Essaid A. Celiac disease associated with sarcoidosis. Gastroenterol. Clin. Biol. 33: 430-432 (2009).

• Reimold AM. TNFalpha as therapeutic target: new drugs, more applications. Curr. Drug Targets Inflamm. Allergy 1: 377-392 (2002).

• Renner P, Roger T, Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin. Infect. Dis. 41 Suppl. 7: S513-S519 (2005). *

• Requena L, Sanchez Yus E. Erythema nodosum. Semin. Cutan. Med. Surg. 26: 114-125 (2007).

• Requena L, Yus ES. Erythema nodosum. Dermatol. Clin. 26: 425-438 (2008).

• Reske D, Petereit HF. Cerebrospinal fluid and immunological parameters for differentiation of chronic inflammatory central nervous system disease. Nervenarzt 75: 945-952 (2004).

• Reske D, Petereit HF, Heiss WD. Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system - value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis. Acta Neurol. Scand. 112: 207-213 (2005). *

• Reynolds HY, Peavy HH, Gail DB, Kiley JP. Past achievements and future directions of sarcoidosis research: a NHLBI perspective. Sarcoidosis Vasc. Diffuse Lung Dis. 23: 83-91 (2006).

• Rhodes B, Chambers D, Musk M, Gabbay E. Pulmonary hypertension complicating sarcoidosis. Intern. Med. J. 38: 613-614 (2008). *

• Richie RC. Sarcoidosis: a review. J. Insur. Med. 37: 283-294 (2005).

• Rigopoulos D, Korfitis C, Gregoriou S, Katsambas AD. Infliximab in dermatological treatment: beyond psoriasis. Expert Opin. Biol. Ther. 8: 123-133 (2008).

• Rodriguez MC, Rani D, Faas FH. Unusual clinical course of Graves' thyrotoxicosis and concomitant sarcoidosis: case report and review of literature. Endocr. Pract. 13: 159-163 (2007).

• Rogers MS, D'Amato RJ. The effect of genetic diversity on angiogenesis. Exp. Cell. Res. 312: 561-574 (2006). *

• Rohart C, Badelon I, Fajnkuchen F, Nghiem-Buffet S, Chaine G. Ophthalmologic disease in sarcoid-like granulomatosis and true sarcoidosis in immunodeficiency. Four case reports. J. Fr. Ophtalmol. 31: 683-691 (2008).

• Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85: 9-18 (2000).

• Romero-Gomez M, Suarez-Garcia E, Otero MA, Rufo MC, Castilla L, Guerrero P, Lopez-Garrido J, Larraona JL, Fernandez MC. Sarcoidosis, sclerosing cholangitis, and chronic atrophic autoimmune gastritis: a case of infiltrative sclerosing cholangitis. J. Clin. Gastroenterol. 27: 162-165 (1998).

• Rose CD, Martin TM. Caspase recruitment domain 15 mutations and rheumatic diseases. Curr. Opin. Rheumatol. 17: 579-585 (2005).

• Rose CD, Wouters CH, Meiorin S, Doyle TM, Davey MP, Rosenbaum JT, Martin TM. Pediatric granulomatous arthritis: an international registry. Arthritis Rheum. 54: 3337-3344 (2006). *

• Rosenbaum JT, Rosenzweig HL, Smith JR, Martin TM, Planck SR. Uveitis secondary to bacterial products. Ophthalmic Res. 40: 165-168 (2008).

• Rosenzweig HL, Galster KT, Planck SR, Rosenbaum JT. NOD1 is expressed in the eye and functionally contributes to IL-1beta dependent ocular inflammation in mice. Invest. Ophthalmol. Vis. Sci. 50: 1746-1753 (2009).

• Rossman MD, Kreider ME. Is chronic beryllium disease sarcoidosis of known etiology? Sarcoidosis Vasc. Diffuse Lung Dis. 20: 104-109 (2003).

• Rossman MD, Kreider ME. Lesson learned from ACCESS (A Case Controlled Etiologic Study of Sarcoidosis). Proc. Am. Thorac. Soc. 4: 453-456 (2007). *

• Rossman MD, Thompson B, Frederick M, Iannuzzi MC, Rybicki BA, Pander JP, Newman LS, Rose C, Magira E, Monos D; ACCESS Group. HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 25: 125-132 (2008).

• Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA, Pandey JP, Newman LS, Magira E, Beznik-Cizman B, Monos D; ACCESS Group. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am. J. Hum. Genet. 73: 720-735 (2003). *

• Rothkrantz-Kos S, Drent M, Rutgers A, Heeringa P, De Vries J, van Dieijen-Visser MP, Cohen Tervaert JW. Relationship between myeloperoxidase promotor polymorphism and disease severity in sarcoidosis. Eur. J. Intern. Med. 14: 296-301 (2003).

• Rudiger T, Hartmann M, Muller-Hermelink HK, Marx A. Inflammatory reactions of the spleen. Pathologe 29: 121-128 (2008).

• Rudzki C, Ishak KG, Zimmerman HJ. Chronic intrahepatic cholestasis of sarcoidosis. Am. J. Med. 59: 373-387 (1975).

• Rutherford RM, Brutsche MH, Kearns M, Bourke M, Stevens F, Gilmartin JJ. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc. Diffuse Lung Dis. 21: 191-198 (2004).

• Rutherford RM, Brutsche MH, Kearns M, Bourke M, Stevens F, Gilmartin JJ. Prevalence of coeliac disease in patients with sarcoidosis. Eur. J. Gastroenterol. Hepatol. 16: 911-915 (2004).

• Rybicki BA, Hirst K, Iyengar SK, Barnard JG, Judson MA, Rose CS, Donohue JF, Kavuru MS, Rabin DL, Rossman MD, Baughman RP, Elston RC, Maliarik MJ, Moller DR, Newman LS, Teirstein AS, Iannuzzi MC. A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study. Sarcoidosis Vasc. Diffuse Lung Dis. 22: 115-122 (2005).

• Rybicki BA, Iannuzzi MC. Epidemiology of sarcoidosis: recent advances and future prospects. Semin. Respir. Crit. Care Med. 28: 22-35 (2007).

• Rybicki BA, Maliarik MJ, Poisson LM, Iannuzzi MC. Sarcoidosis and granuloma genes: a family-based study in African-Americans. Eur. Respir. J. 24: 251-257 (2004). *

• Rybicki BA, Sinha R, Iyengar S, Gray-McGuire C, Elston RC, Iannuzzi MC. Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study. Genes Immun. 8: 379-386 (2007). *

• Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC; ACCESS Research Group. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am. J. Hum. Genet. 77: 491-499 (2005). *

• Saad T, Agmon-Levin N, Shoenfeld Y. Chronic stimulation of the immune system in sarcoidosis and monoclonal gammopathy of undetermined significance. Harefuah. 148: 809-810, 857, 856 (2009).

• Sabounchi-Schutt F, Mikko M, Eklund A, Grunewald J, AStrom J. Serum protein pattern in sarcoidosis analysed by a proteomics approach. Sarcoidosis Vasc. Diffuse Lung Dis. 21: 182-190 (2004).

• Sachar DB, Rochester J. The myth of gastrointestinal sarcoidosis: a case of guilt by association. Inflamm. Bowel Dis. 10: 441-443 (2004). *

• Saini SK, Rose CD. Liver involvement in familial granulomatous arthritis (Blau syndrome). J. Rheumatol. 23: 396-399 (1996).

• Saleh S, Saw C, Marzouk K, Sharma O. Sarcoidosis of the spinal cord: literature review and report of eight cases. J. Natl. Med. Assoc. 98: 965-976 (2006).

• Salobir B, Medica I, Tercelj M, Kastrin A, Sabovic M, Peterlin B. Association of angiotensin-converting enzyme/DD genotype with sarcoidosis susceptibility in Slovenian patients. Med. Sci. Monit. 13: CR538-CR542 (2007). *

• Saltini C, Pallante M, Puxeddu E, Contini S, Voorter CE, Drent M, Amicosante M. M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 25: 100-116 (2008).

• Samokhin AO, Buhling F, Theissig F, Bromme D. ApoE-deficient mice on cholate-containing high-fat diet reveal a pathology similar to lung sarcoidosis. Am. J. Pathol. Jan 21 [Epub ahead of print] (2010). *

• Santo Tomas LH. Beryllium hypersensitivity and chronic beryllium lung disease. Curr. Opin. Pulm. Med. 15: 165-169 (2009).

• Santos E, Shaunak S, Renowden SA, Scolding NJ. Treatment of refractory neurosarcoidosis with infliximab. J. Neurol. Neurosurg. Psychiatry Oct 31 [Epub ahead of print] (2008).

• Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J. Am. Acad. Dermatol. 54: 258-265 (2006).

• Sato H, Grutters JC, Pantelidis P, Mizzon AN, Ahmad T, Van Houte AJ, Lammers JW, Van Den Bosch JM, Welsh KI, Du Bois RM. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am. J. Respir. Cell Mol. Biol. 27: 406-412 (2002). *

• Sato H, Spagnolo P, Silveira L, Welsh KI, du Bois RM, Newman LS, Maier LA. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals. Tissue Antigens 70: 480-486 (2007). *

• Sato H, Williams HR, Spagnolo P, Abdallah A, Ahmad T, Orchard TR, Copley SJ, Desai SR, Wells AU, du Bois RM, Welsh KI. CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis. Eur. Respir. J. Aug 13 [Epub ahead of print] (2009).

• Sato T, Tsuru T, Hagiwara K, Miyashita K, Matsuno H, Goto A, Oritsu M, Hamanaka T, Akiyama O. Sarcoidosis with acute recurrent polyarthritis and hypercalcemia. Intern. Med. 45: 363-368 (2006). *

• Scagliusi P, Sisto M, Lisi S, Lazzari A, D'Amore M. Hashimoto's thyroiditis in Melkersson-Rosenthal syndrome patient: casual association or related diseases? Panminerva Med. 50: 255-257 (2008).

• Schaffer JV, Chandra P, Keegan BR, Heller P, Shin HT. Widespread granulomatous dermatitis of infancy: an early sign of Blau syndrome. Arch. Dermatol. 143: 386-391 (2007). *

• Scherr B, Tromm A, Voigt E, Muller KM, Griga T. Association of primary sclerosing cholangitis and sarcoidosis. Med. Klin. 96: 550-554 (2001).

• Schmid R. Gastroenterology in the next century: megatrends in science and practice. World J. Gastroenterol. 4: 1-3 (1998).

• Schouten JA. Sarcoidosis, a disease with many facets. Ned. Tijdschr. Tandheelkd. 101: 316-318 (1994).

• Schurmann M. Genetics of sarcoidosis. Semin. Respir. Crit. Care Med. 24: 213-222 (2003).

• Schurmann M. Angiotensin-converting enzyme gene polymorphisms in patients with pulmonary sarcoidosis: impact on disease severity. Am. J. Pharmacogenomics 3: 233-243 (2003).

• Schurmann M, Albrecht M, Schwinger E, Stuhrmann M. CFTR gene mutations in sarcoidosis. Eur. J. Hum. Genet. 10: 729-732 (2002). *

• Schurmann M, Kwiatkowski R, Albrecht M, Fischer A, Hampe J, Muller-Quernheim J, Schwinger E, Schreiber S. Study of Toll-like receptor gene loci in sarcoidosis. Clin. Exp. Immunol. 152: 423-431 (2008). *

• Schurmann M, Lympany PA, Reichel P, Muller-Myhsok B, Wurm K, Schlaak M, Muller-Quernheim J, du Bois RM, Schwinger E. Familial sarcoidosis is linked to the major histocompatibility complex region. Am. J. Respir. Crit. Care Med. 162: 861-864 (2000). *

• Schurmann M, Valentonyte R, Hampe J, Muller-Quernheim J, Schwinger E, Schreiber S. CARD15 gene mutations in sarcoidosis. Eur. Respir. J. 22: 748-754 (2003). *

• Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am. Fam. Physician. 75: 695-700 (2007). *

• Sciubba JJ, Said-Al-Naief N. Orofacial granulomatosis: presentation, pathology and management of 13 cases. J. Oral Pathol. Med. 32: 576-585 (2003). *

• Scott DA, Martin M. Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases. World J. Gastroenterol. 12: 7451-7459 (2006). *

• Scott TF, Yandora K, Valeri A, Chieffe C, Schramke C. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch. Neurol. 64: 691-696 (2007).

• Seitzer U, Gerdes J, Muller-Quernheim J. Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis. Respir. Res. 3: 6 (2002). *

• Selva-O'Callaghan A, Labrador-Horrillo M, Gallardo E, Herruzo A, Grau-Junyent JM, Vilardell-Tarres M. Muscle inflammation, autoimmune Addison's disease and sarcoidosis in a patient with dysferlin deficiency. Neuromuscul. Disord. 16: 208-209 (2006).

• Semenzato G. ACCESS: a case control etiologic study of sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 22: 83-86 (2005).

• Seyhan EC, Cetinkaya E, Altin S, Gunluoglu MZ, Demir A, Koksal V, Issever H. Vascular endothelial growth factor gene polymorphisms in Turkish patients with sarcoidosis. Tissue Antigens 72: 162-165 (2008). *

• Seyhan EC, Cetinkaya E, Altin S, Gunluoglu Z, Demir A, Koksal V, Issever H. Tumor necrosis factor gene polymorphisms in Turkish patients with sarcoidosis. Intern. Med. 47: 833-838 (2008). *

• Seyhan EC, Cetinkaya E, Gunluoglu Z, Altin S, Yuksel V, Issever H. Vascular endothelial growth factor and tumor necrosis factor genes polymorphisms in Turkish patients with sarcoidosis. Tuberk. Toraks. 56: 5-14 (2008).

• Shams MG, Motamedi MH, Azizi T. Orofacial granulomatosis of the lower lip and cheek: report of a case. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 104: e42-e44 (2007).

• Sharma OP. Sarcoidosis and other autoimmune disorders. Curr. Opin. Pulm. Med. 8: 452-456 (2002).

• Sharma S, Ghosh B, Sharma SK. Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians. Clin. Exp. Immunol. 151: 251-259 (2008). *

• Sharma SK, Balamurugan A, Pandey RM, Saha PK, Mehra NK. Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am. J. Respir. Cell. Mol. Biol. 29: 225-231 (2003). *

• Sherlock S. The syndrome of disappearing intrahepatic bile ducts. Lancet 2: 493-496 (1987).

• Sherlock S. Overview of chronic cholestatic conditions in adults: terminology and definitions. Clin. Liver Dis. 2: 217-233, vii (1998).

• Sherman S, Nieland NS, Van Thiel DH. Sarcoidosis and primary biliary cirrhosis. Coexistence in a single patient. Dig. Dis. Sci. 33: 368-374 (1988).

• Shetty AK, Gedalia A. Childhood sarcoidosis: a rare but fascinating disorder. Pediatr. Rheumatol. Online J. 6: 16 (2008). *

• Shin JI, Kim DS. Development of sarcoidosis during anti-TNF-alpha treatment: what is the mechanism? Clin. Exp. Rheumatol. 27: 1054 (2009).

• Shinohara MM, Davis C, Olerud J. Concurrent antiphospholipid syndrome and sutaneous sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C. J. Drugs Dermatol. 8: 870-872 (2009).

• Shulimzon T, Rozenman J, Perelman M, Bardan E, Ben-Dov I. Necrotizing granulomata in the lung preceding colonic involvement in 2 patients with Crohn's disease. Respiration 74: 698-702 (2007). *

• Silver MR, Messner LV. Sarcoidosis and its ocular manifestations. J. Am. Optom. Assoc. 65: 321-327 (1994).

• Simmonds MJ, Heward JM, Barrett JC, Franklyn JA, Gough SC. Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves' disease appears to be secondary to DRB1 exon 2 position beta74. Clin. Endocrinol. (Oxf.) 65: 429-432 (2006). *

• Sinha R, Gaur SN. Sarcoidosis presenting as acute bilateral parotid swelling. Asian Pac. J. Allergy Immunol. 22: 171-174 (2004).

• Skoie IM, Wildhagen K, Omdal R. Development of sarcoidosis following etanercept treatment: a report of three cases. Rheumatol. Int. Jan 9 [Epub ahead of print] (2010). *

• Slovakova A, Votava V, Homolka J. Treatment options in sarcoidosis. Cas. Lek. Cesk. 146: 922-924 (2007).

• Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A, Sundstrom C, Akerman M, Melbye M, Glimelius B, Adami HO. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J. Natl. Cancer Inst. 98: 51-60 (2006). *

• Smith G, Brownell I, Sanchez M, Prystowsky S. Advances in the genetics of sarcoidosis. Clin. Genet. 73: 401-412 (2008). *

• Sohl S, Treudler R, Gebhardt C, Harth W, Helbig D, Simon JC. Brownish plaques on both sides of the nose. Hautarzt. 59: 1008-1010 (2008).

• Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ, Moller DR. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J. Exp. Med. 201: 755-767 (2005). *

• Sorrentino D, Avellini C, Zearo E. Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale. Inflamm. Bowel Dis. 10: 438-440 (2004). *

• Spagnolo P, du Bois RM. Genetics of sarcoidosis. Clin. Dermatol. 25: 242-249 (2007).

• Spagnolo P, Richeldi L, du Bois RM. Environmental triggers and susceptibility factors in idiopathic granulomatous diseases. Semin. Respir. Crit. Care Med. 29: 610-619 (2008).

• Spagnolo P, Sato H, Grunewald J, Brynedal B, Hillert J, Mana J, Wells AU, Eklund A, Welsh KI, du Bois RM. A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Lofgren's syndrome. J. Intern. Med. 264: 433-441 (2008). *

• Spagnolo P, Sato H, Grutters JC, Renzoni EA, Marshall SE, Ruven HJ, Wells AU, Tzouvelekis A, van Moorsel CH, van den Bosch JM, du Bois RM, Welsh KI. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens 70: 219-227 (2007). *

• Speeckaert M, Huang G, Delanghe JR, Taes YE. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin. Chim. Acta 372: 33-42 (2006). *

• Spengos K, Vassilopoulou S, Christou Y, Manta P. Sarcoidosis in a case of MuSK-positive myasthenia gravis. Neuromuscul. Disord. 18: 890-891 (2008).

• Stanca CM, Fiel MI, Allina J, Caracta CF, Odin JA. Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin. Liver Dis. 25: 364-370 (2005).

• Steele MP, Brown KK. Genetic predisposition to respiratory diseases: infiltrative lung diseases. Respiration 74: 601-608 (2007). *

• Stern BJ. Neurological complications of sarcoidosis. Curr. Opin. Neurol. 17: 311-316 (2004).

• Stokes DG, Kremer JM. Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis. Semin. Arthritis Rheum. 33: 1-18 (2003). *

• Studdy P, Bird R, James DG. Serum angiotensin-converting enzyme (SACE) in sarcoidosis and other granulomatous disorders. Lancet 2: 1331-1334 (1978).

• Studdy P, Bird, James DG, Sherlock S. Serum angiotensin-converting enzyme (SACE) in sarcoidosis and other granulomatous disorders. Trans. Med. Soc. Lond. 95: 54-59 (1978).

• Studdy PR, Bird R, Neville E, James DG. Biochemical findings in sarcoidosis. J. Clin. Pathol. 33: 528-533 (1980). *

• Sweiss NJ, Curran J, Baughman RP. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts. Clin. Dermatol. 25: 341-346 (2007).

• Sweiss NJ, Hushaw LL. Biologic agents for rheumatoid arthritis: 2008 and beyond. J. Infus. Nurs. 32: S4-S17 (2009).

• Sweiss NJ, Salloum R, Ghandi S, Alegre ML, Sawaqed R, Badaracco M, Pursell K, Pitrak D, Baughman RP, Moller DR, Garcia JG, Niewold TB. Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations. PLoS One 5: e9088 (2010). *

• Szekely H, Ponyai G, Temesvari E, Berczi L, Harsing J, Karpati S, Herszenyi L, Tulassay Z, Juhasz M. Association of collagenous colitis with prurigo nodularis. Eur. J. Gastroenterol. Hepatol. 21: 946-951 (2009).

• Szodoray P, Szollosi Z, Gyimesi E, Takacs I, Mekkel G, Vegh J, Szilagyi A, Zeher M, Szegedi G, Bodolay E. Sarcoidosis in patients with mixed connective tissue disease: clinical, genetic, serological and histological observations. Rheumatol. Int. 28: 743-747 (2008). *

• Szyld P, Jagiello P, Csernok E, Gross WL, Epplen JT. On the Wegener granulomatosis associated region on chromosome 6p21.3. BMC Med. Genet. 7: 21 (2006). *

• Taga M, Abe T, Nishimura S, Kimura H, Oki M, Nojima M, Tanaka H, Matsumoto S, Imai K. A case of Sjogren's syndrome associated with chronic hepatitis C and sarcoidosis. Nihon Rinsho Meneki Gakkai Kaishi 26: 336-340 (2003).

• Tahir M, Sharma SK, Ashraf S, Mishra HK. Angiotensin converting enzyme genotype affects development and course of sarcoidosis in Asian Indians. Sarcoidosis Vasc. Diffuse Lung Dis. 24: 106-112 (2007).

• Takahashi F, Toba M, Takahashi K, Tominaga S, Sato K, Morio Y, Nakao Y, Tajima K, Miura K, Uekusa T, Fukuchi Y. Pulmonary sarcoidosis and antiphospholipid syndrome. Respirology 11: 506-508 (2006). *

• Takano Y, Niimi T, Sato S, Yamada N, Achiwa H, Maeda H, Oguri T, Bessho Y, Miyazaki M, Maeno K, Ozasa H, Ueda R. Effects of FOXP3 gene polymorphism in sarcoidosis patients. Sarcoidosis Vasc. Diffuse Lung Dis. 24: 102-105 (2007).

• Takatori S, Kamata Y, Murosaki T, Iwamoto M, Minota S. Abrupt development of sarcoidosis with a prodromal increase in plasma osteopontin in a patient with rheumatoid arthritis during treatment with etanercept. J. Rheumatol. 37: 210-211 (2010).

• Takizawa Y, Taniuchi N, Ghazizadeh M, Enomoto T, Sato M, Jin E, Azuma A, Gemma A, Kudoh S, Kawanami O. Bronchoalveolar lavage fluid analysis provides diagnostic information on pulmonary Langerhans cell histiocytosis. J. Nippon Med. Sch. 76: 84-92 (2009).

• Tami TA. Granulomatous diseases and chronic rhinosinusitis. Otolaryngol. Clin. North Am. 38: 1267-1278, x (2005).

• Tanabe T, Ishige I, Suzuki Y, Aita Y, Furukawa A, Ishige Y, Uchida K, Suzuki T, Takemura T, Ikushima S, Oritsu M, Yokoyama T, Fujimoto Y, Fukase K, Inohara N, Nunez G, Eishi Y. Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes. Biochim. Biophys. Acta 1762: 794-801 (2006). *

• Tanaka G, Matsushita I, Ohashi J, Tsuchiya N, Ikushima S, Oritsu M, Hijikata M, Nagata T, Yamamoto K, Tokunaga K, Keicho N. Evaluation of microsatellite markers in association studies: a search for an immune-related susceptibility gene in sarcoidosis. Immunogenetics 56: 861-870 (2005). *

• Tattoli I, Travassos LH, Carneiro LA, Magalhaes JG, Girardin SE. The nodosome: Nod1 and Nod2 control bacterial infections and inflammation. Semin. Immunopathol. 29: 289-301 (2007). *

• Tchernev G. Cutaneous sarcoidosis: the "great imitator": etiopathogenesis, morphology, differential diagnosis, and clinical management. Am. J. Clin. Dermatol. 7: 375-382 (2006).

• Teirstein AS, Padilla ML, De Palo LR, Schilero GJ. Sarcoidosis mythology. Mt. Sinai J. Med. 63: 335-341 (1996).

• Terasaki F, Ukimura A, Tsukada B, Fujita S, Katashima T, Otsuka K, Otsuka K, Kanzaki Y, Shimomura H, Fujita M, Tanaka T, Kitaura Y. Enhanced expression of type 1 helper T-cell cytokines in the myocardium of active cardiac sarcoidosis. Circ. J. 72: 1303-1307 (2008). *

• Teufel A, Weinmann A, Kahaly GJ, Centner C, Piendl A, Worns M, Lohse AW, Galle PR, Kanzler S. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J. Clin. Gastroenterol. Jan 15 [Epub ahead of print] (2010).

• Teyton L. The saga of MHC-bound peptides: a renaissance for antigen presentation? J. Clin. Invest. 117: 3164-3166 (2007). *

• Theal RM, Scott K. Evaluating asymptomatic patients with abnormal liver function test results. Am. Fam. Physician 53: 2111-2119 (1996).

• Theodossiadis PG, Markomichelakis NN, Sfikakis PP. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular iInflammation. Retina 27: 399-413 (2007).

• Thielen AM, Barde C, Saurat JH, Laffitte E. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists. Dermatology 219: 59-62 (2009).

• Tombazzi C, Waters B, Ismail MK, Sylvestre PB, Martinez-Hernandez A, Riely CA. Sarcoidosis mimicking primary sclerosing cholangitis requiring liver transplantation. Ann. Hepatol. 7: 83-86 (2008). *

• Torralba KD, Quismorio FP Jr. Sarcoidosis and the rheumatologist. Curr. Opin. Rheumatol. 21: 62-70 (2009).

• Toussirot E, Pertuiset E, Kantelip B, Wendling D. Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases. Clin. Exp. Rheumatol. 26: 471-475 (2008).

• Traczewski P, Rudnicka L. Adalimumab in dermatology. Br. J. Clin. Pharmacol. 66: 618-625 (2008). *

• Traherne JA, Barcellos LF, Sawcer SJ, Compston DA, Ramsay PP, Hauser SL, Oksenberg JR, Trowsdale J. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Hum. Mol. Genet. 15: 155-161 (2006). *

• Tritar F, Zendah I, Ben M'rad S, Daghfous H. Anti-TNF: beneficial or hamful for the lung? Tunis. Med. 87: 607-699 (2009).

• Tsuneyama K, Harada K, Yasoshima M, Hiramatsu K, Mackay CR, Mackay IR, Gershwin ME, Nakanuma Y. Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis. J. Pathol. 193: 102-109 (2001). *

• Tsuneyama K, Yasoshima M, Harada K, Hiramatsu K, Gershwin ME, Nakanuma Y. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology 28: 620-623 (1998). *

• Tsushima K, Tanabe T, Yamamoto H, Koizumi T, Kawa S, Hamano H, Honda T, Uehara T, Kawakami S, Kubo K. Pulmonary involvement of autoimmune pancreatitis. Eur. J. Clin. Invest. 39: 714-722 (2009).

• Tucker ON, Healy V, Jeffers M, Keane FB. Granulomatous appendicitis. Surgeon 1: 286-289 (2003).

• Tuisku IS, Konttinen YT, Soinila S, Karma A, Tervo TM. Neurosarcoidosis mimicking Sjogren's syndrome. Acta Ophthalmol. Scand. 82: 599-602 (2004). *

• Tuohy KA, Steinman TI. Hypercalcemia due to excess 1,25-dihydroxyvitamin D in Crohn's disease. Am. J. Kidney Dis. 45: e3-e6 (2005).

• Tutuncu Z, Morgan GJ Jr, Kavanaugh A. Anti-TNF therapy for other inflammatory conditions. Clin. Exp. Rheumatol. 20 (6 Suppl. 28): S146-S151 (2002).

• Uddenfeldt P, Bjerle P, Danielsson A, Nystrom L, Stjernberg N. Lung function abnormalities in patients with primary biliary cirrhosis. Acta Med. Scand. 223: 549-555 (1988).

• Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE. Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum. 48: 3542-3543 (2003). *

• Unal A, Sipahioglu MH, Akgun H, Yurci A, Tokgoz B, Erkilic K, Oymak O, Utas C. Crohn's disease complicated by granulomatous interstitial nephritis, choroidal neovascularization, and central retinal vein occlusion. Intern. Med. 47: 103-107 (2008). *

• Uthman I. Pharmacological therapy of vasculitis: an update. Curr. Opin. Pharmacol. 4: 177-182 (2004).

• Uzun L, Savranlar A, Altin R, Ugur MB. Mumps virus: a trigger for sarcoidosis? Sarcoidosis Vasc. Diffuse Lung Dis. 21: 237 (2004).

• Vahid B, Spodik M, Braun KN, Ghazi LJ, Esmaili A. Sarcoidosis of gastrointestinal tract: a rare disease. Dig. Dis. Sci. 52: 3316-3320 (2007). *

• Vaiphei K, Gupta N, Sinha SK, Nagi B, Singh K. Association of ulcerative colitis with pulmonary sarcoidosis, subcutaneous lipomatosis and appendiceal adenocarcinoma. Indian J. Gastroenterol. 22: 193-194 (2003).

• Valentonyte R, Hampe J, Croucher PJ, Muller-Quernheim J, Schwinger E, Schreiber S, Schurmann M. Study of C-C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family based analysis. Am. J. Respir. Crit. Care Med. 171: 1136-1141 (2005). *

• Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A, Nagy M, Gaede KI, Franke A, Haesler R, Koch A, Lengauer T, Seegert D, Reiling N, Ehlers S, Schwinger E, Platzer M, Krawczak M, Muller-Quernheim J, Schurmann M, Schreiber S. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat. Genet. 37: 357-364 (2005). *

• Valla D, Pessegueiro-Miranda H, Degott C, Lebrec D, Rueff B, Benhamou JP. Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature. Q. J. Med. 63: 531-544 (1987).

• Valla DC, Benhamou JP. Hepatic granulomas and hepatic sarcoidosis. Clin. Liver Dis. 4: 269-285, ix-x (2000).

• Van Bodegraven AA, Pena AS. Treatment of extraintestinal manifestations in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 6: 201-212 (2003).

• Van Steenbergen W, Fevery J, Vandenbrande P, Desmet V, Ponette E, Kerremans R, de Groote J. Ulcerative colitis, primary sclerosing cholangitis, bile duct carcinoma, and generalized sarcoidosis. Report of a unique association. J. Clin. Gastroenterol. 9: 574-579 (1987).

• Van Steensel MA, Badeloe S, Winnepenninckx V, Vreeburg M, Steijlen PM, Van Geel M. Granulomatous rosacea and Crohn's disease in a patient homozygous for the Crohn-associated NOD2/CARD15 polymorphism R702W. Exp. Dermatol. 17: 1057-1058 (2008).

• Vannozzi G, Tozzi A, Chibbaro G, Mello G, Ponzalli M. Hepatic and mesenteric sarcoidosis without thoracic involvement: a case of severe noncirrhotic portal hypertension and successful pregnancy. Eur. J. Gastroenterol. Hepatol. 20: 1032-1035 (2008).

• Vasakova M, Sterclova M, Kolesar L, Slavcev A, Pohunek P, Sulc J, Skibova J, Striz I. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Scand. J. Immunol. 69: 268-274 (2009). *

• Vass G. Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases. Curr. Med. Chem. 15: 917-922 (2008).

• Veitch AM, Badger I. Sarcoidosis presenting as colonic polyposis: report of a case. Dis. Colon Rectum 47: 937-939 (2004). *

• Veltkamp M, Grutters JC, van Moorsel CH, Ruven HJ, van den Bosch JM. Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients. Clin. Exp. Immunol. 145: 215-218 (2006). *

• Veltkamp M, Wijnen PA, van Moorsel CH, Rijkers GT, Ruven HJ, Heron M, Bekers O, Claessen AM, Drent M, van den Bosch JM, Grutters JC. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin. Exp. Immunol. 149: 453-462 (2007). *

• Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Clin. Rheumatol. 26: 1969-1971 (2007). *

• Vidal M, Ramana CV, Dusso AS. Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription. Mol. Cell. Biol. 22: 2777-2787 (2002). *

• Vignal C, Singer E, Peyrin-Biroulet L, Desreumaux P, Chamaillard M. How NOD2 mutations predispose to Crohn's disease? Microbes Infect. 9: 658-663 (2007). *

• Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann's disease). Orphanet J. Rare Dis. 3: 5 (2008). *

• Voorter CE, Amicosante M, Berretta F, Groeneveld L, Drent M, van den Berg-Loonen EM. HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens 70: 18-27 (2007). *

• Wahlstrom J, Dengjel J, Persson B, Duyar H, Rammensee HG, Stevanovidc S, Eklund A, Weissert R, Grunewald J. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J. Clin. Invest. 117: 3576-3582 (2007). *

• Wahlstrom J, Dengjel J, Winqvist O, Targoff I, Persson B, Duyar H, Rammensee HG, Eklund A, Weissert R, Grunewald J. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin. Immunol. 133: 353-363 (2009). *

• Wainwright H. Hepatic granulomas. Eur. J. Gastroenterol. Hepatol. 19: 93-95 (2007).

• Walker UA, Tyndall A, Daikeler T. Rheumatic conditions in human immunodeficiency virus infection. Rheumatology (Oxford) 47: 952-959 (2008). *

• Wallace DF, Clark RM, Harley HA, Subramaniam VN. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis. J. Hepatol. 40: 710-713 (2004). *

• Wanless IR. Noncirrhotic portal hypertension: recent concepts. Prog. Liver Dis. 14: 265-278 (1996).

• Watanabe T, Kitani A, Strober W. NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn’s disease. Gut 54: 1515-1518 (2005). *

• Waterhouse JC, Perez TH, Albert PJ. Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease. Ann. N. Y. Acad. Sci. 1173: 757-765 (2009). *

• Weisinger HS, Steinfort D, Zimmet AD, Hall AJ, Pesudovs K. Sarcoidosis: case report and review. Clin. Exp. Optom. 89: 361-367 (2006). *

• Westney GE, Habib S, Quarshie A. Comorbid illnesses and chest radiographic severity in African-American sarcoidosis patients. Lung 185: 131-137 (2007).

• Westney GE, Judson MA. Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin. Chest Med. 27: 453-462, vi (2006).

• White ES, Lynch JP 3rd. Current and emerging strategies for the management of sarcoidosis. Expert Opin. Pharmacother. 8: 1293-1311 (2007).

• Wiegand JA, Brutsche MH. Sarcoidosis is a multisystem disorder with variable prognosis - information for treating physicians. Swiss Med. Wkly. 136: 203-209 (2006). *

• Wijnen PA, Nelemans PJ, Verschakelen JA, Bekers O, Voorter CE, Drent M. The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis. Tissue Antigens Jan 11 [Epub ahead of print] (2010). *

• Wiken M, Grunewald J, Eklund A, Wahlstrom J. Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J. Clin. Immunol. 29: 78-89 (2009). *

• Wu JJ, Schiff KR. Sarcoidosis. Am. Fam. Physician 70: 312-322 (2004). *

• Wurm K. Current status of clinical and scientific sarcoidosis research 100 years later. Fortschr. Med. 100: 1560-1563 (1982).

• Xerri L, Nosny Y, Minko D, Benkoel L, Nouhou H, Kohler JL, Chamlian A. Association of sarcoidosis and primary biliary cirrhosis. Clinical and anatomopathologic study of a case followed for over 10 years. Gastroenterol. Clin. Biol. 13: 513-516 (1989).

• Yagi T, Hattori H, Ohira M, Nakamichi K, Takayama-Ito M, Saijo M, Shimizu T, Ito D, Takahashi K, Suzuki N. Progressive multifocal leukoencephalopathy developed in incomplete Heerfordt syndrome, a rare manifestation of sarcoidosis, without steroid therapy responding to cidofovir. Clin. Neurol. Neurosurg. Nov 3 [Epub ahead of print] (2009).

• Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Takahashi H, Imai K. Clinical and pathological differences between Mikulicz's disease and Sjogren's syndrome. Rheumatology (Oxford) 44: 227-234 (2005). *

• Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Shinomura Y, Imai K. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod. Rheumatol. 16: 335-340 (2006). *

• Yan KK, Dinihan I, Freiman J, Zekry A. Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for hepatitis C. Intern. Med. J. 38: 207-210 (2008). *

• Yoshimura T, Sonoda KH, Ohguro N, Ohsugi Y, Ishibashi T, Cua DJ, Kobayashi T, Yoshida H, Yoshimura A. Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology (Oxford) 48: 347-354 (2009). *

• Yoshioka K, Nishimura S, Kitai S, Kondo M. Association of sarcoidosis, insulin-dependent diabetes mellitus, and ulcerative colitis. Arch. Intern. Med. 157: 465, 467 (1997).

• Young RC Jr, Rachal RE, Nelson-Knuckles B, Arthur CN, Nevels HV. Primary care paradigm for management of sarcoidosis, part 2. J. Natl. Med. Assoc. 89: 243-252 (1997).

• Yuksel O, Arhan M, Koklu S, Oguz P, Parlak E. Onerous concomitant complications of ulcerative colitis: a case report. Z. Gastroenterol. 45: 379-381 (2007).

• Zaba LC, Smith GP, Sanchez M, Prystowsky SD. Dendritic cells in the pathogenesis of sarcoidosis. Am. J. Respir. Cell. Mol. Biol. 42: 32-39 (2010). *

• Zampino MR, Corazza M, Borghi A, Marzola A, Virgili A. HLA typing in an IFN-gamma-induced scar sarcoidosis: possible pathogenetic and clinical implications. Acta Derm. Venereol. 89: 661-662 (2009). *

• Zanetti F, Klein R, Berg PA. Progressive inner ear diseases - sequelae of a secondary autoimmune process? Significance of antibodies to endoplasmic reticulum. HNO 35: 34-37 (1987).

• Zhao MH, Lockwood CM. ANCA defines the clinical disease manifestations of vasculitis. Sarcoidosis Vasc. Diffuse Lung Dis. 13: 221-226 (1996).

• Zhernakova A, Alizadeh BZ, Eerligh P, Hanifi-Moghaddam P, Schloot NC, Diosdado B, Wijmenga C, Roep BO, Koeleman BP. Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes. Genes Immun. 7: 544-549 (2006). *

• Ziegenhagen MW, Muller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J. Intern. Med. 253: 18-30 (2003). *

• Zisman DA, Shorr AF, Lynch 3rd JP. Sarcoidosis involving the musculoskeletal system. Semin. Respir. Crit. Care Med. 23: 555-570 (2002).

• Zorzetto M, Ferrarotti I, Campo I, Trisolini R, Poletti V, Scabini R, Ceruti M, Mazzola P, Crippa E, Ottaviani S, Agostini C, Semenzato G, Pozzi E, Luisetti M. NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. Sarcoidosis Vasc. Diffuse Lung Dis. 22: 180-185 (2005).

• Zuber JP, Spertini F, Leimgruber A, Bart PA. Sarcoidosis: new therapeutic and pathogenic aspects for an "old" disease. Rev. Med. Suisse. 1: 1026, 1029-1034, 1036-1038 (2005).

Number of references = 659

www psc-literature.org